<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Curr Mol Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Curr. Mol. Med</journal-id>
      <journal-id journal-id-type="publisher-id">CMM</journal-id>
      <journal-title-group>
        <journal-title>Current Molecular Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1566-5240</issn>
      <issn pub-type="epub">1875-5666</issn>
      <publisher>
        <publisher-name>Bentham Science Publishers</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26391549</article-id>
      <article-id pub-id-type="pmc">5427774</article-id>
      <article-id pub-id-type="publisher-id">CMM-15-714</article-id>
      <article-id pub-id-type="doi">10.2174/1566524015666150921105339</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Integrins as Therapeutic Targets for Respiratory Diseases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Teoh</surname>
            <given-names>C.M.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tan</surname>
            <given-names>S.S.L.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tran</surname>
            <given-names>T.</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <aff id="aff1">Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, <country>Singapore</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Address correspondence to this author at the Department of Physiology, MD9, 2 Medical Drive, National University of Singapore, Singapore 117597, Singapore; Tel: +65 6516-3663;, E-mail: <email xlink:href="tran_thai@nuhs.edu.sg">tran_thai@nuhs.edu.sg</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <volume>15</volume>
      <issue>8</issue>
      <fpage>714</fpage>
      <lpage>734</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>15</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>5</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 Bentham Science Publishers</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/legalcode">
          <license-p>This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (<uri xlink:type="simple" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/legalcode">https://creativecommons.org/licenses/by-nc/4.0/legalcode</uri>), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Integrins are a large family of transmembrane heterodimeric proteins that constitute the main receptors for extracellular matrix components. Integrins were initially thought to be primarily involved in the maintenance of cell adhesion and tissue integrity. However, it is now appreciated that integrins play important roles in many other biological processes such as cell survival, proliferation, differentiation, migration, cell shape and polarity. Lung cells express numerous combinations and permutations of integrin heterodimers. The complexity and diversity of different integrin heterodimers being implicated in different lung diseases present a major challenge for drug development. Here we provide a comprehensive overview of the current knowledge of integrins from studies in cell culture to integrin knockout mouse models and provide an update of results from clinical trials for which integrins are therapeutic targets with a focus on respiratory diseases (asthma, emphysema, pneumonia, lung cancer, pulmonary fibrosis and sarcoidosis).</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Asthma</kwd>
        <kwd>emphysema</kwd>
        <kwd>integrins</kwd>
        <kwd>lung cancer</kwd>
        <kwd>lung disease</kwd>
        <kwd>pulmonary fibrosis</kwd>
        <kwd>sarcoidosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Respiratory disease is defined as any disease that could impair lung functions. There are many types of respiratory diseases which include: 1) asthma and emphysema that obstruct the airflow of the lung, 2) pneumonia resulting from bacteria and virus infection, 3) lung cancer characterized by the uncontrolled growth and spread of abnormal cells, and 4) pulmonary fibrosis and sarcoidosis which stiffen and scar the lung. Despite the current standard treatments for various respiratory diseases, they remain the third leading killer with one in six deaths in the United States [<xref rid="r1" ref-type="bibr">1</xref>]. An estimated 400,000 Americans die from respiratory diseases every year and diseases such as asthma are associated with substantial health impairment and work disability [<xref rid="r1" ref-type="bibr">1</xref>].</p>
      <p>Integrins are a large family of transmembrane proteins that constitute the main receptors for extracellular matrix (ECM) components. Integrins were initially thought to be primarily involved in the maintenance of cell adhesion and tissue integrity. However, further studies demonstrated that integrins also influence cell survival, proliferation, differentiation, migration, shape, polarity and other biological processes [<xref rid="r2" ref-type="bibr">2</xref>-<xref rid="r5" ref-type="bibr">5</xref>].</p>
      <p>Upon interactions with ECM proteins, integrins activate downstream signaling pathways <italic>via</italic> direct or functional association with: 1) intracellular adaptors, such as p130Cas and Grb2; 2) cytosolic tyrosine kinases, such as Src family kinase (SFK) and focal adhesion kinase (FAK); 3) growth factor receptors, such as epidermal growth factor receptor (EGFR) and platelet-derived growth factor (PDGF); and 4) cytokine receptors, such as IL-3 receptor to influence cell behaviors [<xref rid="r6" ref-type="bibr">6</xref>]. With these functions, integrins are implicated in many pathological processes of human respiratory diseases [<xref rid="r7" ref-type="bibr">7</xref>].</p>
      <p>Here, we present an up-to-date review on the diverse biological activities of integrins with respect to their involvement in respiratory diseases, in particular asthma, emphysema, lung cancer, pneumonia, pulmonary fibrosis, and sarcoidosis.</p>
    </sec>
    <sec>
      <title>Integrin gene family</title>
      <p>The integrin family exists as non-covalently linked heterodimers of &#x3B1;- and &#x3B2;-subunits. There are 18 &#x3B1; and 8 &#x3B2; subunits encoded by the human genome. To date, 24 functional integrin receptors have been described <italic>via</italic> various combinations of the &#x3B1; and &#x3B2; subunits [<xref rid="r8" ref-type="bibr">8</xref>]. The ligand binding properties of integrins are defined by the &#x3B1; subunit, while the downstream signaling events are thought to be defined by the &#x3B2; subunit [<xref rid="r9" ref-type="bibr">9</xref>]. Many &#x3B1; subunits associate with only a single &#x3B2; subunit, while some &#x3B1; subunits associate with more than one &#x3B2; subunit (for example, &#x3B1;v may assemble with subunit &#x3B2;1, &#x3B2;3, &#x3B2;5, &#x3B2;6 and &#x3B2;8). Some integrins are able to recognize several ECM proteins, while others bind to only one type of ligand. Although <italic>in vitro</italic> studies have demonstrated considerable functional overlap among the integrin heterodimers, inactivation of individual integrins in mice has produced unique phenotypes (as discussed later). This suggests that the large number of integrins supports an array of unique functions.</p>
      <p>Integrins are transmembrane receptors that mediate bi-directional signals through the cell membrane. On the cell surface, integrins exist in inactive, low affinity conformation states. With exception, Minagawa and colleagues showed that integrin &#x3B1;v&#x3B2;8 adopts a constitutively active, extended-closed headpiece conformation on the cell surface by hydrodynamic, mutational and electron microscopy methods and thus does not fit the conventional models of integrin activation [<xref rid="r10" ref-type="bibr">10</xref>]. It is believed that the function of integrin &#x3B1;v&#x3B2;8 is modulated by the metalloproteolytic cleavage of latent TGF-&#x3B2; [<xref rid="r11" ref-type="bibr">11</xref>]. Integrins can signal through the cell membrane in both directions: inside-out signaling and outside-in signaling. The extracellular binding activity of integrins is regulated from the inside of the cell (inside-out signaling). Switching of affinity state of integrins to an active conformation allows for inside-out signaling. In contrast, the signals that are transmitted into the cells are elicited by the binding of ECM proteins on integrins (outside-in signaling) [<xref rid="r12" ref-type="bibr">12</xref>]. It is through these signaling activation events that integrins regulate cell attachment, survival, proliferation, cell spreading, differentiation, cytoskeleton organization, cell shape, cell migration, gene expression, tumorigenicity, intracellular pH, and increase in concentration of cytosolic Ca<sup>2+</sup> [<xref rid="r13" ref-type="bibr">13</xref>]. To activate downstream signaling pathways, integrins assemble signaling complexes termed &#x201C;integrin adhesome&#x201D; [<xref rid="r14" ref-type="bibr">14</xref>]. There are up to 156 distinct proteins in the integrin adhesome, some of which are fundamental to the adhesion site, while others only transiently associate. The integrin adhesome-associated proteins include talin, paxillin, filamin, integrin-linked kinase (ILK), FAK, p130Cas, SFK and GTPases of the Rho family [<xref rid="r14" ref-type="bibr">14</xref>-<xref rid="r17" ref-type="bibr">17</xref>].</p>
      <p>One of the key signaling events upon integrin ligation is the activation of FAK. FAK is a non-receptor tyrosine kinase with SH2 domain binding sites. Upon integrin activation, integrins cluster and autophosphorylate at position tyrosine 397 (Y397). FAK binds to this phosphorylated site and recruits other proteins containing the SH2 domain. This includes the binding of SFK, leading to increased activation of the FAK-SFK complex which further phosphorylates downstream signaling players. One of the downstream targets of FAK is the Rho family of GTPases, which consists of Rac, Cdc42 and RhoA [<xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r19" ref-type="bibr">19</xref>]. Activation of Rac, Cdc42 and Rho A is critical for the organization of the actin cytoskeleton and for the recruitment of other signaling molecules to the focal adhesion site. FAK activation also recruits phosphatidylinositol-3-kinase (PI3K), leading to the activation of Akt [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r20" ref-type="bibr">20</xref>]. The PI3K-Akt pathway mediates survival signaling <italic>via</italic> increased Bcl-2 protein expression. In addition, FAK represents a crosstalk point with the growth factor receptor pathway [<xref rid="r21" ref-type="bibr">21</xref>]. Studies have shown that the activation of MEK1 and Raf1 <italic>via</italic> integrin mediated FAK-Src signaling is required for MAPK activation [<xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r23" ref-type="bibr">23</xref>]. This suggests that the integrin and growth factor receptor signaling may be integrated <italic>via</italic> the Ras-Raf-MEK-MAPK pathway to regulate key cellular functions such as cell proliferation.</p>
    </sec>
    <sec>
      <title>Integrin expression in the lung</title>
      <p>Integrins are expressed in various lung cell types and they may play important roles in regulating lung development. These include branching morphogenesis, epithelial cell polarization and differentiation. To determine the role of specific integrins in lung development, various studies have been done to investigate the expression patterns of integrins in foetal, human and murine lung developments [<xref rid="r24" ref-type="bibr">24</xref>-<xref rid="r27" ref-type="bibr">27</xref>].</p>
      <p>Eight different integrins which include &#x3B1;2&#x3B2;1, &#x3B1;3&#x3B2;1, &#x3B1;5&#x3B2;1, &#x3B1;6&#x3B2;4, &#x3B1;9&#x3B2;1, &#x3B1;v&#x3B2;5, &#x3B1;v&#x3B2;6 and &#x3B1;v&#x3B2;8 are found to be expressed on human airway epithelial cells [<xref rid="r28" ref-type="bibr">28</xref>-<xref rid="r33" ref-type="bibr">33</xref>]. The expression patterns of these integrins in epithelial cells are different. For example, integrins &#x3B1;3 and &#x3B1;6 are diffusely expressed across the epithelial cells but integrin &#x3B1;2 is only found to be expressed on the branching tips of the cells [<xref rid="r27" ref-type="bibr">27</xref>]. Although epithelial cells express integrins &#x3B1;3 and &#x3B1;6, the subcellular distribution of these integrins are developmentally regulated. Young epithelial cells express integrins &#x3B1;3 and &#x3B1;6 pericellularly. As epithelial cells mature, they express integrins &#x3B1;3 and &#x3B1;6 basally [<xref rid="r27" ref-type="bibr">27</xref>, <xref rid="r34" ref-type="bibr">34</xref>-<xref rid="r36" ref-type="bibr">36</xref>]. This suggests that integrins &#x3B1;3 and &#x3B1;6 might play an important role in lung epithelial maturation, development and basement membrane organization, whereas integrin &#x3B1;2 may be responsible for assembly and extension of epithelial tubule into mesenchyme in branching morphogeneisis. Integrins &#x3B1;2&#x3B2;1 and &#x3B1;3&#x3B2;1 are thought to play key roles in homotypic cell-cell interaction in the epithelium [<xref rid="r37" ref-type="bibr">37</xref>-<xref rid="r39" ref-type="bibr">39</xref>]. However, the significance of this finding is uncertain since other studies have shown that there are no defects in epithelial cell-cell interactions in either integrin &#x3B1;2- or &#x3B1;3-null mice [<xref rid="r40" ref-type="bibr">40</xref>-<xref rid="r42" ref-type="bibr">42</xref>]. The integrin &#x3B1;6&#x3B2;4 is found to be important for the maintenance of epithelial integrity. This is evident by integrin &#x3B1;6- or &#x3B2;4-null mice which die soon after birth due to severe skin blistering [<xref rid="r43" ref-type="bibr">43</xref>, <xref rid="r44" ref-type="bibr">44</xref>]. The other integrins (&#x3B1;5&#x3B2;1, &#x3B1;9&#x3B2;1 and &#x3B1;v&#x3B2;5) are not expressed in healthy human epithelial cells but are rapidly induced on these cells upon lung inflammation and injury [<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r32" ref-type="bibr">32</xref>, <xref rid="r45" ref-type="bibr">45</xref>, <xref rid="r46" ref-type="bibr">46</xref>]. Thus, these integrins serve as detectors to allow the lung cells to sense and respond to injury and inflammation in the lung.</p>
      <p>Integrins such as &#x3B1;1&#x3B2;1, &#x3B1;2&#x3B2;1, &#x3B1;5&#x3B2;1 and &#x3B1;v&#x3B2;3 are expressed on lung endothelial cells. Wu and colleagues demonstrated that integrin &#x3B1;1 is stained positively on the airway endothelial cells and large blood vessels while integrin &#x3B1;2 is present on lung mesenchymal cells which mainly constitute the endothelium [<xref rid="r27" ref-type="bibr">27</xref>]. Another study showed that integrins &#x3B1;5&#x3B2;1 and &#x3B1;v&#x3B2;3 are expressed on the mesenchyme of the embryonic lungs [<xref rid="r47" ref-type="bibr">47</xref>]. This is supported by another study showing that integrin &#x3B1;v&#x3B2;3 is extensively evident in the endothelium of alveolar micro-vessels and vascular smooth muscle [<xref rid="r48" ref-type="bibr">48</xref>]. Taken together, these studies suggest that the integrins expressed on lung endothelial cells may regulate blood vessel formation and microvascular permeability.</p>
      <p>Other integrins such as &#x3B1;2&#x3B2;1, &#x3B1;4&#x3B2;1, &#x3B1;5&#x3B2;1, and &#x3B1;11 are expressed on lung fibroblasts, whilst integrins &#x3B1;5&#x3B2;1, &#x3B1;7&#x3B2;1 and &#x3B1;v&#x3B2;5 are expressed on airway smooth muscle. Integrins &#x3B1;4&#x3B2;1, &#x3B1;5&#x3B2;1, &#x3B1;E&#x3B2;7 and &#x3B2;2 are expressed on respiratory T lymphocytes and leukocytes [<xref rid="r7" ref-type="bibr">7</xref>, <xref rid="r49" ref-type="bibr">49</xref>-<xref rid="r56" ref-type="bibr">56</xref>]. Collectively, all these studies demonstrate that there are differential expression of integrins during lung development and dysregulation of their expression in the lungs may contribute to respiratory diseases.</p>
    </sec>
    <sec>
      <title>Integrins and their association with respiratory diseases</title>
      <p>Table <bold><xref ref-type="table" rid="T1">1</xref></bold> summarizes the distribution of integrins in various lung cell types and their association with respiratory diseases. Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) illustrates integrin expressions in various respiratory diseases.</p>
    </sec>
    <sec>
      <title>INTEGRIN &#x3B1;1&#x3B2;1 IN ANGIOGENESIS</title>
      <p>The integrin &#x3B1;1&#x3B2;1 plays a key role in angiogenesis (formation of new blood vessels) and its expression is elevated in asthma, non-small-cell lung cancer (NSCLC) and sarcoidosis [<xref rid="r57" ref-type="bibr">57</xref>-<xref rid="r59" ref-type="bibr">59</xref>]. In asthma, angiogenesis constitutes one of the structural changes seen in airway wall remodeling. Activation of integrin &#x3B1;1&#x3B2;1 on endothelial cells is essential for VEGF-induced angiogenesis within the airway [<xref rid="r57" ref-type="bibr">57</xref>], thus promoting airway wall remodeling in asthmatic subjects. In NSCLC, the tumors are smaller and less vascularised in KrasLA2/&#x3B1;1-null mice when compared with KrasLA2/ &#x3B1;1 wild-type mice [<xref rid="r58" ref-type="bibr">58</xref>]. This suggests that the integrin &#x3B1;1&#x3B2;1 is involved in the growth of Kras-induced NSCLC, potentially by promoting angiogenesis.</p>
    </sec>
    <sec>
      <title>INTEGRIN &#x3B1;4&#x3B2;1 IN INFLAMMATION</title>
      <p>The integrin &#x3B1;4&#x3B2;1 is expressed on cells in inflammatory diseases such as asthma, sarcoidosis and pulmonary fibrosis. Accumulation of leukocytes, mainly eosinophils in the airway is one of the characteristic features of asthma [<xref rid="r60" ref-type="bibr">60</xref>]. The integrin &#x3B1;4&#x3B2;1-expressing eosinophils are able to transmigrate across human pulmonary microvascular VCAM-1-expressing endothelial cells [<xref rid="r61" ref-type="bibr">61</xref>]. Sarcoidosis is a chronic lung inflammation characterized by the accumulation of lymphocytes in the lung [<xref rid="r7" ref-type="bibr">7</xref>]. The over-expression of integrin &#x3B1;4&#x3B2;1 in human lymphocytes during sarcoidosis aids lymphocyte extravasation to the site of inflammation within the lung [<xref rid="r49" ref-type="bibr">49</xref>]. Collectively, these studies suggest that the integrin &#x3B1;4&#x3B2;1 plays an essential role in the recruitment of pro-inflammatory cells to the lung, contributing to inflammatory diseases.</p>
    </sec>
    <sec>
      <title>INTEGRIN &#x3B1;5&#x3B2;1 IN SURVIVAL AND ADHESION/ MIGRATION</title>
      <p>The integrin &#x3B1;5&#x3B2;1 is associated with asthma, epithelial injury and repair, NSCLC, pulmonary fibrosis and sarcoidosis due to its diverse roles in cell signaling. It primarily regulates the survival and adhesion/ migration signaling pathways. The expression of</p>
      <p>integrin &#x3B1;5&#x3B2;1 and its ECM ligand fibronectin are increased in the asthmatic airways [<xref rid="r62" ref-type="bibr">62</xref>]. Thus, the integrin mediated survival signaling from ECM proteins may be one of the mechanisms underlying the increased bulk of smooth muscle cells in airway wall remodeling [<xref rid="r53" ref-type="bibr">53</xref>]. In epithelial injury and repair, integrin &#x3B1;5&#x3B2;1 is required for epithelial cell migration and spreading for wound closure [<xref rid="r32" ref-type="bibr">32</xref>]. In NSCLC, increased expression of integrin &#x3B1;5&#x3B2;1 enhanced tumor cell survival and invasiveness on disrupted collagen matrix [<xref rid="r63" ref-type="bibr">63</xref>]. During pulmonary fibrosis, increased numbers of fibroblasts have been attributed to the migration/i nvasion of lung fibroblasts across the basement membrane to the site of wound <italic>via</italic> integrin &#x3B1;5&#x3B2;1-fibronectin signaling, leading to scarring of the lung [<xref rid="r51" ref-type="bibr">51</xref>]. In sarcoidosis, the integrin &#x3B1;5&#x3B2;1-fibronectin signaling is required for lymphocyte adhesion to the endothelial cells and their subsequent migration to the site of inflammation [<xref rid="r49" ref-type="bibr">49</xref>, <xref rid="r50" ref-type="bibr">50</xref>]. Taken together, these studies demonstrate that the integrin &#x3B1;5&#x3B2;1 is essential for the survival and adhesion/migration signaling of various cells in respiratory diseases.</p>
    </sec>
    <sec>
      <title>INTEGRIN &#x3B1;V&#x3B2;6 IN TGF&#x3B2; SIGNALING</title>
      <p>The integrin &#x3B1;v&#x3B2;6 mediates emphysema, NSCLC, pulmonary fibrosis, acute lung injury, influenza infection, epithelial injury and repair due to its ability to activate the TGF&#x3B2; signaling pathway. Studies on integrin &#x3B2;6 knockout mice suggest that integrin &#x3B1;v&#x3B2;6 may play a role in emphysema [<xref rid="r64" ref-type="bibr">64</xref>, <xref rid="r65" ref-type="bibr">65</xref>]. Loss of integrin &#x3B1;v&#x3B2;6 leads to the loss of latent TGF&#x3B2; activation. Since TGF&#x3B2; inhibits macrophage metalloelastase (MMP12), there is also a marked induction of MMP12 that degrades elastin. Therefore, integrin &#x3B1;6-null mice eventually develop age-dependent emphysema. In NSCLC, integrin &#x3B1;v&#x3B2;6 activates the release of active TGF&#x3B2; from the ECM to promote tumor progression and invasion [<xref rid="r66" ref-type="bibr">66</xref>, <xref rid="r67" ref-type="bibr">67</xref>]. In patients with pulmonary fibrosis, integrin &#x3B1;v&#x3B2;6 is over-expressed in pneumocytes lining the alveolar ducts and alveoli [<xref rid="r68" ref-type="bibr">68</xref>]. Additionally, integrin &#x3B1;v&#x3B2;6 are dramatically upregulated in murine-model of bleomycin-induced pulmonary fibrosis [<xref rid="r69" ref-type="bibr">69</xref>]. The lungs of bleomycin-induced pulmonary fibrosis mice contained higher percentage and greater intensity of integrin &#x3B1;v&#x3B2;6-positive epithelial cells than the saline-treated mice [<xref rid="r69" ref-type="bibr">69</xref>]. The use of a blocking antibody further revealed that the partial inhibition of integrin &#x3B1;v&#x3B2;6 activation inhibits murine TGF&#x3B2;-mediated pulmonary fibrosis [<xref rid="r68" ref-type="bibr">68</xref>]. Jenkins and colleagues demonstrated that protease-activated receptor 1 activates TGF&#x3B2; in an integrin &#x3B1;v&#x3B2;6-dependent manner <italic>via</italic> RhoA and Rho kinase signaling [<xref rid="r70" ref-type="bibr">70</xref>]. Another group while using lysophosphatidic acid to induce integrin &#x3B1;v&#x3B2;6-mediated activation of TGF&#x3B2; showed that G<sub>&#x3B1;q</sub> is an important link between integrin &#x3B1;v&#x3B2;6 to RhoA and Rho kinase signaling [<xref rid="r71" ref-type="bibr">71</xref>]. This pathway is a critical step in the development of acute lung injury and fibrosis [<xref rid="r70" ref-type="bibr">70</xref>, <xref rid="r71" ref-type="bibr">71</xref>]. Jolly and colleagues also demonstrated that the influenza virus infection led to increased integrin &#x3B1;v&#x3B2;6-mediated TGF&#x3B2; activation. The functional consequence of this is epithelial cell apoptosis and increased collagen deposition, which are critical steps in exacerbations of pulmonary fibrosis [<xref rid="r72" ref-type="bibr">72</xref>, <xref rid="r73" ref-type="bibr">73</xref>]. Collectively, these studies demonstrate that the integrin &#x3B1;v&#x3B2;6 is an activator of TGF&#x3B2; and that functional alterations in the TGF&#x3B2; signaling pathway increase the susceptibility to emphysema, NSCLC and pulmonary fibrosis.</p>
    </sec>
    <sec>
      <title>Integrin 71 in airway wall remodeling</title>
      <p>Airway wall remodeling is a prominent feature of asthma that contributes to chronic symptoms [<xref rid="r74" ref-type="bibr">74</xref>-<xref rid="r76" ref-type="bibr">76</xref>]. Airway wall remodeling is defined by a number of structural changes including increased mass of contractile airway smooth muscle cells, and fibrosis resulting from the accumulation of ECM proteins such as laminin. Increased expression of laminin is associated with asthma [<xref rid="r77" ref-type="bibr">77</xref>]. Our laboratory has recently demonstrated that the integrin 71 and its ECM protein laminin maintain and regulate contractile ASM phenotype and cell survival. This contributes to airway hyperresponsiveness and supports the enlargement of muscle bundles encircling the airways, a critical feature of airway wall remodeling [<xref rid="r75" ref-type="bibr">75</xref>]. Findings from our study suggests that targeting the laminin-integrin 71 signaling axis may offer new avenues for the development of therapies to reduce dysfunctions associated with contractile ASM cells in asthmatic patients.</p>
    </sec>
    <sec>
      <title>INTEGRIN &#x3B1;E&#x3B2;7 IN RESPIRATORY DISEASES</title>
      <p>The expression of the integrin &#x3B1;E&#x3B2;7 is enhanced on lymphocytes in the bronchoalveolar lavage fluid of patients with asthma, pneumonia and pulmonary fibrosis [<xref rid="r55" ref-type="bibr">55</xref>]. The integrin &#x3B1;E&#x3B2;7 is expressed only on lymphocytes of the intraepithelial phenotype [<xref rid="r78" ref-type="bibr">78</xref>, <xref rid="r79" ref-type="bibr">79</xref>]. The only ligand for this integrin is the epithelial E-cadherin. The precise role of integrin &#x3B1;E&#x3B2;7 in these respiratory diseases is yet unknown but it has been suggested to be involved in the selective retention of lymphocytes in mucosal tissues of the lung during disease progression [<xref rid="r55" ref-type="bibr">55</xref>]. Further study in this area is warranted.</p>
    </sec>
    <sec>
      <title>Matricellular proteins and their association with integrins in respiratory diseases</title>
      <sec>
        <title>Thrombospondin (TSP-1)</title>
        <p>TSP-1 is a major constituent of human blood platelets and it functions at the cell surface to bring together membrane proteins and cytokines that regulate the ECM and cellular phenotype [<xref rid="r80" ref-type="bibr">80</xref>]. TSP-1 interacts with integrins and is involved in respiratory diseases such as pneumonia, small cell lung carcinoma (SCLC) and pulmonary fibrosis.</p>
        <p>Abnormalities were observed in the lungs of TSP-1 deficient mice. There is increased inflammatory cell infiltrates, fibroblastic and epithelial cell hyperplasia and matrix deposition in the lungs of these mice, and hemosiderein-laden macrophages were observed suggesting diffuse alveolar hemorrhage [<xref rid="r81" ref-type="bibr">81</xref>]. TSP-1 binds to integrins &#x3B1;4&#x3B2;1 and &#x3B1;5&#x3B2;1 in activated T-cell adhesion [<xref rid="r82" ref-type="bibr">82</xref>]. The binding of TSP-1 to integrins may aid in neutrophil adhesion and migration, monocytes chemotaxis, haptotaxis, and diapedesis [<xref rid="r83" ref-type="bibr">83</xref>-<xref rid="r85" ref-type="bibr">85</xref>]. The aberrant inflammation in TSP-1 deficient mice could be due to defects in recruitment and clearance of inflammatory cells <italic>via</italic> integrins. This results in pneumonia in the lungs of TSP-1 deficient mice, suggesting that TSP-1 is required in normal lung homoestasis [<xref rid="r81" ref-type="bibr">81</xref>].</p>
        <p>In SCLC, the adhesion of cancer cells to TSP-1 was inhibited by heparin (integrin &#x3B1;3&#x3B2;1 inhibitor) [<xref rid="r86" ref-type="bibr">86</xref>]. The adhesion of SCLC cells to TSP-1 <italic>via</italic> integrin &#x3B1;3&#x3B2;1 induced neurite-like outgrowth and inhibited SCLC proliferation [<xref rid="r86" ref-type="bibr">86</xref>]. The TSP-1-integrin &#x3B1;3&#x3B2;1-induced neurotypic differentiation of SCLC is further enhanced by epidermal growth factor (EGF), suggesting that TSP-1 and EGF work synergistically to induce differentiation of SCLC <italic>via</italic> integrin &#x3B1;3&#x3B2;1 [<xref rid="r86" ref-type="bibr">86</xref>].</p>
        <p>TSP-1 deficient mice are not protected from bleomycin-induced pulmonary fibrosis. These mice manifested higher expression of connective tissue growth factor and collagen deposition compared with wild type control mice [<xref rid="r87" ref-type="bibr">87</xref>]. This suggests that TSP-1 may basally suppress connective tissue growth factor and collagen expression. Moreover, TSP-1 deficiency appears to worsen pulmonary fibrosis in response to bleomycin. As TGF&#x3B2; is involved in pulmonary fibrosis [<xref rid="r88" ref-type="bibr">88</xref>] and integrin &#x3B1;v&#x3B2;6 mediates TGF&#x3B2; activation [<xref rid="r89" ref-type="bibr">89</xref>], TSP-1 may mediate the integrin &#x3B1;6&#x3B2;1-TGF&#x3B2; activation in the pathogenesis of pulmonary fibrosis.</p>
      </sec>
    </sec>
    <sec>
      <title>SPARC</title>
      <p>Secreted Protein Acidic and Rich in Cysteine (SPARC) is a matricellular protein that mediates tissue repair and wound healing, and is a known target of TGF&#x3B2; [<xref rid="r90" ref-type="bibr">90</xref>]. SPARC interacts with integrins and is involved in pulmonary fibrosis.</p>
      <p>Immunohistochemical staining revealed that SPARC was observed in fibroblast of Masson bodies, fibroblast foci and interstitial fibroblast in pulmonary fibrosis [<xref rid="r91" ref-type="bibr">91</xref>]. SPARC binds to collagen III but not fibronectin [<xref rid="r92" ref-type="bibr">92</xref>]. Fibroblasts in the interstitial compartment of alveolar walls (collagen III rich) migrate to exudates in alveoli (fibronectin rich) during pulmonary fibrosis. Taken together, this suggests that SPARC may function early in pulmonary fibrosis by aiding fibroblast migration. SPARC regulates the production of integrin in an integrin-linked kinase-dependent manner [<xref rid="r93" ref-type="bibr">93</xref>-<xref rid="r95" ref-type="bibr">95</xref>]. Barker and colleagues also demonstrated that SPARC modulates integrin-linked kinase activity in fibroblasts [<xref rid="r96" ref-type="bibr">96</xref>]. This suggests that migration of fibroblasts from alveolar walls to exudates in alveoli by SPARC may be integrin-dependent. Chang and colleagues showed that fibroblasts in pulmonary fibrosis have higher survival rate [<xref rid="r97" ref-type="bibr">97</xref>]. This may be attributed to elevated levels of SPARC which activates the PI3-Akt pathway <italic>via</italic> integrin, thus leading to glycogen synthase kinase-3&#x3B2; (GSK-3&#x3B2;) inhibition and &#x3B2;-catenin activation. &#x3B2;-catenin activation increased expression of plasminogen activator inhibitor-1 (PAI-1) which suppresses fibroblast apoptosis in pulmonary fibrosis. Therefore, the inhibition of SPARC-induced &#x3B2;-catenin signaling pathway may be a novel therapeutic target for pulmonary fibrosis [<xref rid="r97" ref-type="bibr">97</xref>].</p>
      <sec>
        <title>Periostin</title>
        <p>Periostin is an extracellular matrix protein induced by IL-4 and IL-13 in airway epithelial cells [<xref rid="r98" ref-type="bibr">98</xref>]. Its expression is also induced by TGF&#x3B2; in fibroblasts [<xref rid="r98" ref-type="bibr">98</xref>]. Periostin interacts with integrins to mediate allergic lung inflammation, asthma, NSCLC and pulmonary fibrosis.</p>
        <p>Allergen-challenged periostin-deficient mice developed reduced eosinophil infiltration in the lung compared with wild type mice [<xref rid="r99" ref-type="bibr">99</xref>]. This suggests a direct role of periostin in promoting allergen-induced eosinophil infiltration into the allergic inflammatory lungs. Recently, Takayama and colleagues demonstrated an upregulation of periostin in the lung epithelial cells by IL-13 and in the lungs of allergen-challenged wild-type mice [<xref rid="r98" ref-type="bibr">98</xref>]. Furthermore, periostin binds to integrins &#x3B1;v&#x3B2;3 and &#x3B1;v&#x3B2;5 to mediate fibroblast or malignant cell migration [<xref rid="r100" ref-type="bibr">100</xref>]. This suggests that the integrins expressed on eosinophils may bind to periostin on lung epithelial cells and thereby facilitate eosinophil recruitment to the lung of allergen-challenged mice.</p>
        <p>In asthma, periostin deficiency leads to an increase in airway resistance and mucus production [<xref rid="r101" ref-type="bibr">101</xref>]. Allergen sensitization and challenge in periostin deficient mice had significantly higher PAS-staining index and Muc5ac and Gob5 expression compared with wild-type mice. This suggests that periostin attenuates mucus production that leads to airway resistance in asthma. Given that periostin binds to integrins &#x3B1;v&#x3B2;3 and &#x3B1;v&#x3B2;5 in cancer cells for adhesion and migration [<xref rid="r100" ref-type="bibr">100</xref>], it may also bind to integrins &#x3B1;4 and &#x3B2;1/2 which are involved in asthma development and thus downregulate mucus production by repressing mucus production genes such as NF-B. SP-1, and AP-1 [<xref rid="r102" ref-type="bibr">102</xref>]. The secretion of periostin is increased in lung fibroblasts in response to IL-4 and IL-13 stimulation, which are novel components of subepithelial fibrosis in bronchial asthma [<xref rid="r98" ref-type="bibr">98</xref>]. Secreted periostin binds ECM proteins such as fibronection, tenascin-C and collagen V [<xref rid="r98" ref-type="bibr">98</xref>]. Since the ECM proteins induce downstream signaling pathways <italic>via</italic> integrins, periostin-bound ECM proteins could potentially activate integrins, contributing to features of asthma.</p>
        <p>In NSCLC, chemical hypoxia mimicking reagents increase periostin expression. The hypoxia responsive genes TGF&#x3B1; and bFGF induce the upregulation of periostin that in turn activates RTK/PI3K signaling cascade [<xref rid="r103" ref-type="bibr">103</xref>]. This signaling cascade confers survival of NSCLC. Bao and colleagues showed that periostin binds to integrin &#x3B1;v&#x3B2;3 to promote cancer cell metastasis by activating the PI3K/Akt survival signaling pathway [<xref rid="r104" ref-type="bibr">104</xref>]. This suggests that periostin may interact with integrins to promote NSCLC survival <italic>via</italic> PI3K/Akt pathway.</p>
        <p>In pulmonary fibrosis, periostin levels are elevated. Immunohistochemical staining showed that periostin stained mainly in areas of active fibrosis in the lung [<xref rid="r105" ref-type="bibr">105</xref>]. Okamoto and colleagues detected increased periostin levels in the lung of pulmonary fibrosis patients compared with healthy controls [<xref rid="r106" ref-type="bibr">106</xref>]. Periostin knockout mice were also protected from bleomycin-induced pulmonary fibrosis [<xref rid="r107" ref-type="bibr">107</xref>]. Collectively, this suggests an important role of periostin in pulmonary fibrosis. Naik and colleagues demonstrated that TGF&#x3B2; upregulates periostin expression in mesenchymal cells. Periostin in turn regulates ECM protein deposition, mesenchymal cell proliferation and wound closure, which are features of pulmonary fibrosis [<xref rid="r105" ref-type="bibr">105</xref>]. This suggests that TGF&#x3B2;-induced periostin play an important role in the late stages of pulmonary fibrosis. Importantly, when OC-20, an antibody that prevents periostin from binding to integrin, was administered 10 days post-bleomycin treatment in wild type mice, it significantly reduced bleomycin-associated fibrosis [<xref rid="r105" ref-type="bibr">105</xref>]. This suggests that periostin binds to integrin to mediate pulmonary fibrosis in the lung.</p>
      </sec>
    </sec>
    <sec>
      <title>Phenotypes of integrin knockout mice in relation to the lung</title>
      <p>The availability of integrin knockout mice <italic>via</italic> gene targeting technology has increased our understanding of integrin functions. It reveals the unique functions each integrin have in the lung <italic>in vivo</italic>, whereby the deletion of a specific integrin results in distinctive phenotypes not shared by null mutations of other integrins. This is in contrast to the overlapping functions of integrins demonstrated <italic>in vitro</italic>. Table <bold><xref ref-type="table" rid="T2">2</xref></bold> summarizes the phenotypes of integrin knockout mice in relation to the lung.</p>
      <p>Using integrin &#x3B1;1 knockout mice, Pozzi and colleagues showed that integrin &#x3B1;1 plays an important role in blood vessel formation in the lungs. Tumors implanted into these mice had reduced vascularization (reduced capillary number and size) [<xref rid="r108" ref-type="bibr">108</xref>]. This is due to the loss of integrin &#x3B1;1-induced tumor endothelial cell proliferation. In the same study, isolated &#x3B1;1-null endothelial cells from the lung also had reduced proliferation on the substrata. This suggests that the role of integrin &#x3B1;1 in angiogenesis is not restricted to tumor endothelial cells but also in the normal lung endothelial cells.</p>
      <p>Kreidberg and colleagues demonstrated that the integrin &#x3B1;3 knockout mice showed severe decrease in bronchial branching and maturation of distal bronchioles [<xref rid="r109" ref-type="bibr">109</xref>]. In combination with other organ defects such as kidneys and cerebral cortex, integrin &#x3B1;3 knockout leads to death of mice shortly after birth [<xref rid="r109" ref-type="bibr">109</xref>-<xref rid="r111" ref-type="bibr">111</xref>]. Although both integrins &#x3B1;3 and &#x3B1;6 are expressed on lung epithelial cells, either integrin &#x3B1;3 or &#x3B1;6 knockout mice have normal lung development without any obvious lung defects [<xref rid="r112" ref-type="bibr">112</xref>]. Nonetheless, mice with double homozygous mutant for integrins &#x3B1;3 and &#x3B1;6 develop bilateral lung hypoplasia; a phenomenon characterized by low number and size of bronchopulmonary segments or alveoli in the lung [<xref rid="r113" ref-type="bibr">113</xref>]. This defect is not observed in either integrin &#x3B1;3 or &#x3B1;6 knockout mice, suggesting that the integrins &#x3B1;3 and &#x3B1;6 synergize in the normal development of the lung. It also suggests that the lack of either one integrin function may be compensated by the other to prevent bilateral lung hypoplasia.</p>
      <p>Huang and colleagues showed that integrin &#x3B1;9 gene knockout mice exhibit increased volumes of pleural fluid, giving rise to bilateral chylothorax and respiratory failure [<xref rid="r114" ref-type="bibr">114</xref>]. The integrin &#x3B1;9-null mice also develop edema and lymphocytic infiltration (rich in lymphocytes, triglyceride, and cholesterol) in the chest wall. This study suggests that the integin &#x3B1;9 plays a critical role in the development of the thoracic duct and other lymphatic vessels essential for lung development.</p>
      <p>Overall, studies in integrin knockout mice provided evidence that integrins promote respiratory disease progression and regulation of inflammation. The integrin &#x3B2;5 knockout mice were protected from increased vascular permeability in a model of acute lung injury [<xref rid="r115" ref-type="bibr">115</xref>]. This may be attributed to decreased angiogenesis resulting from the loss of integrin &#x3B2;5 on the pulmonary endothelial cells. The integrin &#x3B1;v&#x3B2;6 knockout mice showed age-dependent pulmonary emphysema due to the loss of TGF&#x3B2; activation, leading to increased Mmp12 levels in the integrin &#x3B1;v&#x3B2;6-null mice and promoting emphysema development [<xref rid="r65" ref-type="bibr">65</xref>]. Integrin &#x3B2;6 knockout mice also had severe lung inflammation (elevated lymphocyte accumulation in the conducting airways) and exhibited airway hyperresponsiveness to acetylcholine, a hallmark of asthma [<xref rid="r64" ref-type="bibr">64</xref>]. An enhanced lung inflammation observed in integrin &#x3B2;6 knockout mice suggests the role of integrin &#x3B1;v&#x3B2;6 in downregulating inflammatory responses [<xref rid="r89" ref-type="bibr">89</xref>]. In this study, integrin &#x3B2;6 knockout mice are protected from bleomycin-induced pulmonary fibrosis, a model that is critically dependent on TGF&#x3B2; signaling. This protection against pulmonary fibrosis is not due to the downregulation of inflammatory response to bleomycin [<xref rid="r89" ref-type="bibr">89</xref>]. This suggests that integrin &#x3B1;v&#x3B2;6 plays an important role in the development of pulmonary fibrosis.</p>
    </sec>
    <sec>
      <title>Integrins in clinical trials</title>
      <p>The diverse roles of integrins in the pathogenesis of respiratory diseases have placed them as potential targets for therapeutic interventions. Table <bold><xref ref-type="table" rid="T3">3</xref></bold> summarizes the integrin antagonists that are currently in the development for the treatment of respiratory diseases such as asthma and NSCLC.</p>
      <p>Currently, only the integrin &#x3B1;4&#x3B2;1 is being targeted for the treatment of inflammation in asthma. This is because integrin &#x3B1;4&#x3B2;1 recruits leukocytes into the airway and exacerbates inflammation <italic>via</italic> VCAM and ICAM interactions [<xref rid="r61" ref-type="bibr">61</xref>, <xref rid="r116" ref-type="bibr">116</xref>-<xref rid="r118" ref-type="bibr">118</xref>]. Integrin antagonists such as Valategrast (R411), IVL745, Bio 1211, GW-559090X, HMR 1031 and TR14035 target these interactions [<xref rid="r119" ref-type="bibr">119</xref>, <xref rid="r120" ref-type="bibr">120</xref>]. Nonetheless, they have failed to be effective during clinical trials. It is unclear whether the failure is due to the route of administration, bioavailability of the drugs, or attributed to functional compensation by the other integrins. Such integrins include integrin &#x3B1;5&#x3B2;1, which is found to be important for lymphocytes migration into the lung during sarcoidosis [<xref rid="r49" ref-type="bibr">49</xref>, <xref rid="r50" ref-type="bibr">50</xref>].</p>
      <p>Besides using integrin antagonists to treat inflammation in asthma, other aspects of asthma such as airway wall remodeling should also be considered. The formation of tortuous blood vessels and accumulation of smooth muscle bulks are common structural changes in asthmatic airways [<xref rid="r121" ref-type="bibr">121</xref>]. These processes are mainly regulated by integrins such as integrin &#x3B1;1&#x3B2;1 that increases angiogenesis and integrin &#x3B1;5&#x3B2;1 that mediates survival signals to airway smooth muscle cells [<xref rid="r53" ref-type="bibr">53</xref>]. Hence, drug therapies targeting the integrins &#x3B1;1&#x3B2;1 and &#x3B1;5&#x3B2;1 are warranted for the treatment of asthma. Airway wall remodeling is characterized by inflammation and fibrosis (increased deposition of ECM proteins) that deteriorates lung function. TGF&#x3B2;, a pleiotropic cytokine that drives the inflammation and matrix deposition is implicated in asthmatic and COPD airway remodeling [<xref rid="r122" ref-type="bibr">122</xref>-<xref rid="r124" ref-type="bibr">124</xref>]. The activation of TGF&#x3B2; is integrin &#x3B1;v&#x3B2;5- and &#x3B1;v&#x3B2;8-dependent and these two integrins have been shown to be expressed on airway smooth muscle cells (&#x3B1;v&#x3B2;5) and airway fibroblasts (&#x3B1;v&#x3B2;8) and their expression are increased in asthma and COPD [<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r56" ref-type="bibr">56</xref>, <xref rid="r125" ref-type="bibr">125</xref>]. Hence, integrins &#x3B1;v&#x3B2;5 and &#x3B1;v&#x3B2;8 represent attractive targets for the treatment of airway remodeling in asthma and COPD.</p>
      <p>Besides utilizing integrin antagonists, integrin inhibitors have been conjugated to cytotoxic drugs. This is done by synthetic chemistry or by coupling the inhibitors to biomacromolecules <italic>via</italic> DNA recombination technology or fusion protein technology to facilitate drug delivery into the targeted cells, such as cancerous cells in NSCLC and leukocytes in asthma [<xref rid="r126" ref-type="bibr">126</xref>]. For example, the ACDCRGDCFC peptide is conjugated with the antimicrobial synthetic peptide (KLAKLAK)<sub>2</sub> and targets the integrins &#x3B1;v&#x3B2;3 and &#x3B1;v&#x3B2;6 in NSCLC [<xref rid="r127" ref-type="bibr">127</xref>]. ACDCRGDCFC is a targeting domain for integrins &#x3B1;v&#x3B2;3 and &#x3B1;v&#x3B2;6, which homes the proapoptotic peptide to the targeted cells for further internalization. (KLAKLAK)<sub>2</sub> is a proapoptotic domain. This conjugation is designed to be toxic only when internalized into the cells because it specifically disrupts mitochondrial membranes. It shows significant tumour reducing effect and reduced lung metastasis burden in preclinical trials [<xref rid="r127" ref-type="bibr">127</xref>].</p>
      <p>Some integrin antagonists are applied in combination with the standard anti-cancer therapies. One such example is Vitaxin II which targets the integrin &#x3B1;v&#x3B2;3 in NSCLC. It is currently under Phase I clinical trial [<xref rid="r19" ref-type="bibr">19</xref>]. Other integrin antagonists that are currently under Phase II clinical trials for NSCLC are Cilengitide and Volociximab. Cilengitide targets the integrins &#x3B1;v&#x3B2;3 and &#x3B1;v&#x3B2;5 whereas Volociximab targets the integrin &#x3B1;5&#x3B2;1. Both drugs have anti-angiogenic effect in NSCLC and showed encouraging safety profiles in Phase I trials [<xref rid="r128" ref-type="bibr">128</xref>, <xref rid="r129" ref-type="bibr">129</xref>].</p>
      <p>Currently, there are only 3 integrins (&#x3B1;v&#x3B2;3, &#x3B1;v&#x3B2;5 and &#x3B1;5&#x3B2;1) targeted in NSCLC. These integrins are targeted mainly for their anti-angiogenic function in tumors. Given that other integrins (&#x3B1;1, &#x3B1;11 and &#x3B1;v&#x3B2;6) are also involved in NSCLC disease progression, antagonists against these integrins should be considered for therapeutic development [<xref rid="r52" ref-type="bibr">52</xref>, <xref rid="r58" ref-type="bibr">58</xref>, <xref rid="r66" ref-type="bibr">66</xref>, <xref rid="r67" ref-type="bibr">67</xref>].</p>
      <p>The study of integrin antagonists should also be extended to other lung diseases such as emphysema, epithelial injury and repair, pulmonary fibrosis, pneumonia and sarcoidosis, whereby integrins play important roles (Table <bold><xref ref-type="table" rid="T1">1</xref></bold>).</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>We have reviewed and highlighted the importance of integrins in mediating various respiratory disease progressions. Integrins are promising therapeutic targets. Nonetheless, the complexity and diversity of integrins present a major challenge for drug development. Recent advances in the understanding of the integrin function and their signaling mechanisms using the gene knockout technology have aided in the development of integrin antagonists. This is coupled with the possibility of altering integrin signaling in respiratory diseases. Collectively, drugs targeting integrins hold great potential for the treatment of respiratory diseases in the future.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGEMENTS</title>
      <p>TT received funding support from the Singapore Ministry of Health&#x2019;s National Medical Research Council under its IRG scheme (NMRC/1215/2009).</p>
    </ack>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ECM</term>
          <def>
            <p>Extracellular matrix</p>
          </def>
        </def-item>
        <def-item>
          <term>EGFR</term>
          <def>
            <p>Epidermal growth factor receptor</p>
          </def>
        </def-item>
        <def-item>
          <term>FAK</term>
          <def>
            <p>Focal adhesion kinase</p>
          </def>
        </def-item>
        <def-item>
          <term>GALT</term>
          <def>
            <p>Gut associated lymphoid tissues</p>
          </def>
        </def-item>
        <def-item>
          <term>ILK</term>
          <def>
            <p>Integrin-linked kinase</p>
          </def>
        </def-item>
        <def-item>
          <term>MLN</term>
          <def>
            <p>Mesenteric lymph nodes</p>
          </def>
        </def-item>
        <def-item>
          <term>MMP12</term>
          <def>
            <p>Macrophage metalloelastase</p>
          </def>
        </def-item>
        <def-item>
          <term>NSCLC</term>
          <def>
            <p>Non-small cell lung cancer</p>
          </def>
        </def-item>
        <def-item>
          <term>NSCLC</term>
          <def>
            <p>non-small cell lung cancer</p>
          </def>
        </def-item>
        <def-item>
          <term>PDGF</term>
          <def>
            <p>Platelet-derived growth factor</p>
          </def>
        </def-item>
        <def-item>
          <term>PI3K</term>
          <def>
            <p>Phosphatidylinositol-3-kinase</p>
          </def>
        </def-item>
        <def-item>
          <term>PMN</term>
          <def>
            <p>Polymorphonuclear leucocytes</p>
          </def>
        </def-item>
        <def-item>
          <term>SFK</term>
          <def>
            <p>Src family kinase</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <sec>
      <title>CONFLICT OF INTEREST</title>
      <p>The authors confirm that this article content has no conflict of interest.</p>
    </sec>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mini&#xF1;o</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Heron</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>S.L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deaths: final data for 2004.</article-title>
          <source>Natl. Vital Stat. Rep.</source>
          <year>2007</year>
          <volume>55</volume>
          <issue>19</issue>
          <fpage>1</fpage>
          <lpage>119</lpage>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hynes</surname>
              <given-names>R.O.</given-names>
            </name>
          </person-group>
          <article-title>Integrins: versatility, modulation, and signaling in cell adhesion.</article-title>
          <source>Cell</source>
          <year>1992</year>
          <volume>69</volume>
          <issue>1</issue>
          <fpage>11</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">1555235</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hood</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Cheresh</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Role of integrins in cell invasion and migration.</article-title>
          <source>Nat. Rev. Cancer</source>
          <year>2002</year>
          <volume>2</volume>
          <issue>2</issue>
          <fpage>91</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">12635172</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Humphries</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Integrin structure.</article-title>
          <source>Biochem. Soc. Trans.</source>
          <year>2000</year>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>311</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="pmid">10961914</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giancotti</surname>
              <given-names>F.G.</given-names>
            </name>
            <name>
              <surname>Ruoslahti</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Integrin signaling.</article-title>
          <source>Science</source>
          <year>1999</year>
          <volume>285</volume>
          <issue>5430</issue>
          <fpage>1028</fpage>
          <lpage>1032</lpage>
          <pub-id pub-id-type="pmid">10446041</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cabodi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Di Stefano</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Integrins and signal transduction.</article-title>
          <source>Adv. Exp. Med. Biol.</source>
          <year>2010</year>
          <volume>674</volume>
          <fpage>43</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="pmid">20549939</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bazan-Socha</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bukiej</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Marcinkiewicz</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrins in pulmonary inflammatory diseases.</article-title>
          <source>Curr. Pharm. Des.</source>
          <year>2005</year>
          <volume>11</volume>
          <issue>7</issue>
          <fpage>893</fpage>
          <lpage>901</lpage>
          <pub-id pub-id-type="pmid">15777242</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van der Flier</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sonnenberg</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Function and interactions of integrins.</article-title>
          <source>Cell Tissue Res.</source>
          <year>2001</year>
          <volume>305</volume>
          <issue>3</issue>
          <fpage>285</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="pmid">11572082</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cox</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Moran</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Integrins as therapeutic targets: lessons and opportunities.</article-title>
          <source>Nat. Rev. Drug Discov.</source>
          <year>2010</year>
          <volume>9</volume>
          <issue>10</issue>
          <fpage>804</fpage>
          <lpage>820</lpage>
          <pub-id pub-id-type="pmid">20885411</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minagawa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lou</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Seed</surname>
              <given-names>R.I.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Selective targeting of TGF-&#x3B2; activation to treat fibroinflammatory airway disease.</article-title>
          <source>Sci. Transl. Med.</source>
          <year>2014</year>
          <volume>6</volume>
          <issue>241</issue>
          <fpage>241ra79</fpage>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Cambier</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fjellbirkeland</surname>
              <given-names>L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1.</article-title>
          <source>J. Cell Biol.</source>
          <year>2002</year>
          <volume>157</volume>
          <issue>3</issue>
          <fpage>493</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="pmid">11970960</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giancotti</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ruoslahti</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Integrin signaling.</article-title>
          <source>Science</source>
          <year>1999</year>
          <volume>285</volume>
          <issue>5430</issue>
          <fpage>1028</fpage>
          <lpage>1032</lpage>
          <pub-id pub-id-type="pmid">10446041</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors.</article-title>
          <source>Cardiovasc. Res.</source>
          <year>2004</year>
          <volume>63</volume>
          <issue>3</issue>
          <fpage>81</fpage>
          <lpage>90</lpage>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaidel-Bar</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Itzkovitz</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ma'ayan</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional atlas of the integrin adhesome.</article-title>
          <source>Nat. Cell Biol.</source>
          <year>2007</year>
          <volume>9</volume>
          <issue>8</issue>
          <fpage>858</fpage>
          <lpage>867</lpage>
          <pub-id pub-id-type="pmid">17671451</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harburger</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Calderwood</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Integrin signalling at a glance.</article-title>
          <source>J. Cell Sci.</source>
          <year>2009</year>
          <volume>122</volume>
          <issue>Pt 2</issue>
          <fpage>159</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">19118207</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Legate</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Wickstrom</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Fassler</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Genetic and cell biological analysis of integrin outside-in signaling.</article-title>
          <source>Genes Dev.</source>
          <year>2009</year>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>397</fpage>
          <lpage>418</lpage>
          <pub-id pub-id-type="pmid">19240129</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Welsh</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Assoian</surname>
              <given-names>R.K.</given-names>
            </name>
          </person-group>
          <article-title>A growing role for Rho family GTPases as intermediaries in growth factor- and adhesion-dependent cell cycle progression.</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>2000</year>
          <volume>1471</volume>
          <issue>1</issue>
          <fpage>M21</fpage>
          <lpage>M29</lpage>
          <pub-id pub-id-type="pmid">11004606</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanks</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Calalb</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>M.C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin.</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>1992</year>
          <volume>89</volume>
          <issue>18</issue>
          <fpage>8487</fpage>
          <lpage>8491</lpage>
          <pub-id pub-id-type="pmid">1528852</pub-id>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huveneers</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Truong</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Danen</surname>
              <given-names>H.J.</given-names>
            </name>
          </person-group>
          <article-title>Integrins: signaling, disease, and therapy.</article-title>
          <source>Int. J. Radiat. Biol.</source>
          <year>2007</year>
          <volume>83</volume>
          <issue>11-12</issue>
          <fpage>743</fpage>
          <lpage>751</lpage>
          <pub-id pub-id-type="pmid">17852562</pub-id>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Turnbull</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Guimond</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor.</article-title>
          <source>J. Endocrinol.</source>
          <year>2011</year>
          <volume>209</volume>
          <issue>2</issue>
          <fpage>139</fpage>
          <lpage>151</lpage>
          <pub-id pub-id-type="pmid">21307119</pub-id>
        </element-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Antagonistic effect of EGF on FAK phosphorylation/dephosphorylation in a cell.</article-title>
          <source>Cell Biochem. Funct.</source>
          <year>2008</year>
          <volume>26</volume>
          <issue>5</issue>
          <fpage>539</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="pmid">18543351</pub-id>
        </element-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Slack-Davis</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Eblen</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Zecevic</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation.</article-title>
          <source>J. Cell Biol.</source>
          <year>2003</year>
          <volume>162</volume>
          <issue>2</issue>
          <fpage>281</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="pmid">12876277</pub-id>
        </element-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edin</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Juliano</surname>
              <given-names>R.L.</given-names>
            </name>
          </person-group>
          <article-title>Raf-1 serine 338 phosphorylation plays a key role in adhesion-dependent activation of extracellular signal-regulated kinase by epidermal growth factor.</article-title>
          <source>Mol. Cell. Biol.</source>
          <year>2005</year>
          <volume>25</volume>
          <issue>11</issue>
          <fpage>4466</fpage>
          <lpage>4475</lpage>
          <pub-id pub-id-type="pmid">15899852</pub-id>
        </element-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheppard</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Functions of pulmonary epithelial integrins: from development to disease.</article-title>
          <source>Physiol. Rev.</source>
          <year>2003</year>
          <volume>83</volume>
          <issue>3</issue>
          <fpage>673</fpage>
          <lpage>686</lpage>
          <pub-id pub-id-type="pmid">12843406</pub-id>
        </element-citation>
      </ref>
      <ref id="r25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coraux</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Delplanque</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hinnrasky</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distribution of integrins during human fetal lung development.</article-title>
          <source>J. Histochem. Cytochem.</source>
          <year>1998</year>
          <volume>46</volume>
          <issue>7</issue>
          <fpage>803</fpage>
          <lpage>810</lpage>
          <pub-id pub-id-type="pmid">9632739</pub-id>
        </element-citation>
      </ref>
      <ref id="r26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wagner</surname>
              <given-names>T.E.</given-names>
            </name>
            <name>
              <surname>Frevert</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Herzog</surname>
              <given-names>E.L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of the integrin subunit alpha8 in murine lung development.</article-title>
          <source>J. Histochem. Cytochem.</source>
          <year>2003</year>
          <volume>51</volume>
          <issue>10</issue>
          <fpage>1307</fpage>
          <lpage>1315</lpage>
          <pub-id pub-id-type="pmid">14500699</pub-id>
        </element-citation>
      </ref>
      <ref id="r27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Santoro</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Differential expression of integrin alpha subunits supports distinct roles during lung branching morphogenesis.</article-title>
          <source>Dev. Dyn.</source>
          <year>1996</year>
          <volume>206</volume>
          <issue>2</issue>
          <fpage>169</fpage>
          <lpage>181</lpage>
          <pub-id pub-id-type="pmid">8725284</pub-id>
        </element-citation>
      </ref>
      <ref id="r28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cambier</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mu</surname>
              <given-names>D.Z.</given-names>
            </name>
            <name>
              <surname>O'Connell</surname>
              <given-names>D.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A role for the integrin alphavbeta8 in the negative regulation of epithelial cell growth.</article-title>
          <source>Cancer Res.</source>
          <year>2000</year>
          <volume>60</volume>
          <issue>24</issue>
          <fpage>7084</fpage>
          <lpage>7093</lpage>
          <pub-id pub-id-type="pmid">11156415</pub-id>
        </element-citation>
      </ref>
      <ref id="r29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Damjanovich</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Albelda</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Mette</surname>
              <given-names>S.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distribution of integrin cell adhesion receptors in normal and malignant lung tissue.</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>1992</year>
          <volume>6</volume>
          <issue>2</issue>
          <fpage>197</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="pmid">1540382</pub-id>
        </element-citation>
      </ref>
      <ref id="r30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mette</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Pilewski</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Buck</surname>
              <given-names>C.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells <italic>in vitro</italic> and <italic>in vivo.</italic></article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>1993</year>
          <volume>8</volume>
          <issue>5</issue>
          <fpage>562</fpage>
          <lpage>572</lpage>
          <pub-id pub-id-type="pmid">8481237</pub-id>
        </element-citation>
      </ref>
      <ref id="r31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palmer</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>Ruegg</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ferrando</surname>
              <given-names>R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle.</article-title>
          <source>J. Cell Biol.</source>
          <year>1993</year>
          <volume>123</volume>
          <issue>5</issue>
          <fpage>1289</fpage>
          <lpage>1297</lpage>
          <pub-id pub-id-type="pmid">8245132</pub-id>
        </element-citation>
      </ref>
      <ref id="r32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pilewski</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Latoche</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Arcasoy</surname>
              <given-names>S.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of integrin cell adhesion receptors during human airway epithelial repair <italic>in vivo.</italic></article-title>
          <source>Am. J. Physiol.</source>
          <year>1997</year>
          <volume>273</volume>
          <issue>1 Pt 1</issue>
          <fpage>L256</fpage>
          <lpage>L263</lpage>
          <pub-id pub-id-type="pmid">9252563</pub-id>
        </element-citation>
      </ref>
      <ref id="r33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinacker</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ferrando</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Elliott</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distribution of integrins alpha v beta 6 and alpha 9 beta 1 and their known ligands, fibronectin and tenascin, in human airways.</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>1995</year>
          <volume>12</volume>
          <issue>5</issue>
          <fpage>547</fpage>
          <lpage>556</lpage>
          <pub-id pub-id-type="pmid">7537970</pub-id>
        </element-citation>
      </ref>
      <ref id="r34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Korhonen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yl&#xE4;nne</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Laitinen</surname>
              <given-names>L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The alpha 1-alpha 6 subunits of integrins are characteristically expressed in distinct segments of developing and adult human nephron.</article-title>
          <source>J. Cell Biol.</source>
          <year>1990</year>
          <volume>111</volume>
          <issue>3</issue>
          <fpage>1245</fpage>
          <lpage>1254</lpage>
          <pub-id pub-id-type="pmid">2144000</pub-id>
        </element-citation>
      </ref>
      <ref id="r35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kadoya</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kadoya</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Durbeej</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antibodies against domain E3 of laminin-1 and integrin alpha 6 subunit perturb branching epithelial morphogenesis of submandibular gland, but by different modes.</article-title>
          <source>J. Cell Biol.</source>
          <year>1995</year>
          <volume>129</volume>
          <issue>2</issue>
          <fpage>521</fpage>
          <lpage>534</lpage>
          <pub-id pub-id-type="pmid">7536749</pub-id>
        </element-citation>
      </ref>
      <ref id="r36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sorokin</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sonnenberg</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Aumailley</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recognition of the laminin E8 cell-binding site by an integrin possessing the alpha 6 subunit is essential for epithelial polarization in developing kidney tubules.</article-title>
          <source>J. Cell Biol.</source>
          <year>1990</year>
          <volume>111</volume>
          <issue>3</issue>
          <fpage>1265</fpage>
          <lpage>1273</lpage>
          <pub-id pub-id-type="pmid">2144001</pub-id>
        </element-citation>
      </ref>
      <ref id="r37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carter</surname>
              <given-names>W.G.</given-names>
            </name>
            <name>
              <surname>Wayner</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Bouchard</surname>
              <given-names>T.S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells.</article-title>
          <source>J. Cell Biol.</source>
          <year>1990</year>
          <volume>110</volume>
          <issue>4</issue>
          <fpage>1387</fpage>
          <lpage>1404</lpage>
          <pub-id pub-id-type="pmid">1691191</pub-id>
        </element-citation>
      </ref>
      <ref id="r38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sriramarao</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Steffner</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Gehlsen</surname>
              <given-names>K.R.</given-names>
            </name>
          </person-group>
          <article-title>Biochemical evidence for a homophilic interaction of the alpha 3 beta 1 integrin.</article-title>
          <source>J. Biol. Chem.</source>
          <year>1993</year>
          <volume>268</volume>
          <issue>29</issue>
          <fpage>22036</fpage>
          <lpage>22041</lpage>
          <pub-id pub-id-type="pmid">8408061</pub-id>
        </element-citation>
      </ref>
      <ref id="r39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Symington</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Takada</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>W.G.</given-names>
            </name>
          </person-group>
          <article-title>Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: potential role in keratinocyte intercellular adhesion.</article-title>
          <source>J. Cell Biol.</source>
          <year>1993</year>
          <volume>120</volume>
          <issue>2</issue>
          <fpage>523</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="pmid">8421064</pub-id>
        </element-citation>
      </ref>
      <ref id="r40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tenchini</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Gilberty</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence against a major role for integrins in calcium-dependent intercellular adhesion of epidermal keratinocytes.</article-title>
          <source>Cell Adhes. Commun.</source>
          <year>1993</year>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>55</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">7521749</pub-id>
        </element-citation>
      </ref>
      <ref id="r41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weitzman</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hemler</surname>
              <given-names>M.E.</given-names>
            </name>
          </person-group>
          <article-title>Investigation of the role of beta 1 integrins in cell-cell adhesion.</article-title>
          <source>J. Cell Sci.</source>
          <year>1995</year>
          <volume>108</volume>
          <issue>Pt 11</issue>
          <fpage>3635</fpage>
          <lpage>3644</lpage>
          <pub-id pub-id-type="pmid">8586674</pub-id>
        </element-citation>
      </ref>
      <ref id="r42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weitzman</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Pasqualini</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Takada</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation.</article-title>
          <source>J. Biol. Chem.</source>
          <year>1993</year>
          <volume>268</volume>
          <issue>12</issue>
          <fpage>8651</fpage>
          <lpage>8657</lpage>
          <pub-id pub-id-type="pmid">8473308</pub-id>
        </element-citation>
      </ref>
      <ref id="r43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Georges-Labouesse</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Messaddeq</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Yehia</surname>
              <given-names>G.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice.</article-title>
          <source>Nat. Genet.</source>
          <year>1996</year>
          <volume>13</volume>
          <issue>3</issue>
          <fpage>370</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="pmid">8673141</pub-id>
        </element-citation>
      </ref>
      <ref id="r44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van der Neut</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Krimpenfort</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Calafat</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice.</article-title>
          <source>Nat. Genet.</source>
          <year>1996</year>
          <volume>13</volume>
          <issue>3</issue>
          <fpage>366</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="pmid">8673140</pub-id>
        </element-citation>
      </ref>
      <ref id="r45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Huet</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tarui</surname>
              <given-names>T.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions.</article-title>
          <source>J. Biol. Chem.</source>
          <year>2002</year>
          <volume>277</volume>
          <issue>20</issue>
          <fpage>17804</fpage>
          <lpage>17810</lpage>
          <pub-id pub-id-type="pmid">11882657</pub-id>
        </element-citation>
      </ref>
      <ref id="r46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Busk</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pytela</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sheppard</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein.</article-title>
          <source>J. Biol. Chem.</source>
          <year>1992</year>
          <volume>267</volume>
          <issue>9</issue>
          <fpage>5790</fpage>
          <lpage>5796</lpage>
          <pub-id pub-id-type="pmid">1532572</pub-id>
        </element-citation>
      </ref>
      <ref id="r47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roman</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Potential role of RGD-binding integrins in mammalian lung branching morphogenesis.</article-title>
          <source>Development</source>
          <year>1991</year>
          <volume>112</volume>
          <issue>2</issue>
          <fpage>551</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="pmid">1794323</pub-id>
        </element-citation>
      </ref>
      <ref id="r48">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bhattacharya</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Vascular expression of the alpha(v)beta(3)-integrin in lung and other organs.</article-title>
          <source>Am. J. Physiol. Lung Cell. Mol. Physiol.</source>
          <year>2000</year>
          <volume>278</volume>
          <issue>1</issue>
          <fpage>L217</fpage>
          <lpage>L226</lpage>
          <pub-id pub-id-type="pmid">10645910</pub-id>
        </element-citation>
      </ref>
      <ref id="r49">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berlin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lundahl</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Skold</surname>
              <given-names>C.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The lymphocytic alveolitis in sarcoidosis is associated with increased amounts of soluble and cell-bound adhesion molecules in bronchoalveolar lavage fluid and serum.</article-title>
          <source>J. Intern. Med.</source>
          <year>1998</year>
          <volume>244</volume>
          <issue>4</issue>
          <fpage>333</fpage>
          <lpage>340</lpage>
          <pub-id pub-id-type="pmid">9797497</pub-id>
        </element-citation>
      </ref>
      <ref id="r50">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shigehara</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Shijubo</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Hirasawa</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immunolocalization of extracellular matrix proteins and integrins in sarcoid lymph nodes.</article-title>
          <source>Virchows Arch.</source>
          <year>1998</year>
          <volume>433</volume>
          <issue>1</issue>
          <fpage>55</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">9692826</pub-id>
        </element-citation>
      </ref>
      <ref id="r51">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Thannickal</surname>
              <given-names>V.J.</given-names>
            </name>
            <name>
              <surname>Carskadon</surname>
              <given-names>S.L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10.</article-title>
          <source>Am. J. Respir. Crit. Care Med.</source>
          <year>2003</year>
          <volume>168</volume>
          <issue>4</issue>
          <fpage>436</fpage>
          <lpage>442</lpage>
          <pub-id pub-id-type="pmid">12791582</pub-id>
        </element-citation>
      </ref>
      <ref id="r52">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>C.Q.</given-names>
            </name>
            <name>
              <surname>Popova</surname>
              <given-names>S.N.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>E.R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2007</year>
          <volume>104</volume>
          <issue>28</issue>
          <fpage>11754</fpage>
          <lpage>11759</lpage>
          <pub-id pub-id-type="pmid">17600088</pub-id>
        </element-citation>
      </ref>
      <ref id="r53">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freyer</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells.</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>2001</year>
          <volume>25</volume>
          <issue>5</issue>
          <fpage>569</fpage>
          <lpage>576</lpage>
          <pub-id pub-id-type="pmid">11713098</pub-id>
        </element-citation>
      </ref>
      <ref id="r54">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tran</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ens-Blackie</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Rector</surname>
              <given-names>E.S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Laminin-binding integrin alpha7 is required for contractile phenotype expression by human airway myocytes.</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>2007</year>
          <volume>37</volume>
          <issue>6</issue>
          <fpage>668</fpage>
          <lpage>680</lpage>
          <pub-id pub-id-type="pmid">17641293</pub-id>
        </element-citation>
      </ref>
      <ref id="r55">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lohmeyer</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Grimminger</surname>
              <given-names>F.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases.</article-title>
          <source>Clin. Exp. Immunol.</source>
          <year>1999</year>
          <volume>116</volume>
          <issue>2</issue>
          <fpage>340</fpage>
          <lpage>346</lpage>
          <pub-id pub-id-type="pmid">10337028</pub-id>
        </element-citation>
      </ref>
      <ref id="r56">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tatler</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>John</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Jolly</surname>
              <given-names>L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrin &#x3B1;v&#x3B2;5-mediated TGF-&#x3B2; activation by airway smooth muscle cells in asthma.</article-title>
          <source>J. Immunol.</source>
          <year>2011</year>
          <volume>187</volume>
          <issue>11</issue>
          <fpage>6094</fpage>
          <lpage>6107</lpage>
          <pub-id pub-id-type="pmid">22025551</pub-id>
        </element-citation>
      </ref>
      <ref id="r57">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Senger</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Claffey</surname>
              <given-names>K.P.</given-names>
            </name>
            <name>
              <surname>Benes</surname>
              <given-names>J.E.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins.</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>1997</year>
          <volume>94</volume>
          <issue>25</issue>
          <fpage>13612</fpage>
          <lpage>13617</lpage>
          <pub-id pub-id-type="pmid">9391074</pub-id>
        </element-citation>
      </ref>
      <ref id="r58">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macias-Perez</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Borza</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer.</article-title>
          <source>Cancer Res.</source>
          <year>2008</year>
          <volume>68</volume>
          <issue>15</issue>
          <fpage>6127</fpage>
          <lpage>6135</lpage>
          <pub-id pub-id-type="pmid">18676835</pub-id>
        </element-citation>
      </ref>
      <ref id="r59">
        <label>59</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berlin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lundahl</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sk&#xF6;ld</surname>
              <given-names>C.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The lymphocytic alveolitis in sarcoidosis is associated with increased amounts of soluble and cell-bound adhesion molecules in bronchoalveolar lavage fluid and serum.</article-title>
          <source>J. Intern. Med.</source>
          <year>1998</year>
          <volume>244</volume>
          <issue>4</issue>
          <fpage>333</fpage>
          <lpage>340</lpage>
          <pub-id pub-id-type="pmid">9797497</pub-id>
        </element-citation>
      </ref>
      <ref id="r60">
        <label>60</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohashi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Motojima</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fukuda</surname>
              <given-names>T.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma.</article-title>
          <source>Am. Rev. Respir. Dis.</source>
          <year>1992</year>
          <volume>145</volume>
          <issue>6</issue>
          <fpage>1469</fpage>
          <lpage>1476</lpage>
          <pub-id pub-id-type="pmid">1596020</pub-id>
        </element-citation>
      </ref>
      <ref id="r61">
        <label>61</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagata</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tabe</surname>
              <given-names>K.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Eosinophil transmigration across VCAM-1-expressing endothelial cells is upregulated by antigen-stimulated mononuclear cells.</article-title>
          <source>Int. Arch. Allergy Immunol.</source>
          <year>2001</year>
          <volume>125</volume>
          <issue>Suppl. 1</issue>
          <fpage>7</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">11408764</pub-id>
        </element-citation>
      </ref>
      <ref id="r62">
        <label>62</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hocking</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>Fibronectin matrix deposition and cell contractility: implications for airway remodeling in asthma.</article-title>
          <source>Chest</source>
          <year>2002</year>
          <volume>122</volume>
          <issue>6</issue>
          <supplement>Suppl.</supplement>
          <fpage>275S</fpage>
          <lpage>278S</lpage>
          <pub-id pub-id-type="pmid">12475798</pub-id>
        </element-citation>
      </ref>
      <ref id="r63">
        <label>63</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S.H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis.</article-title>
          <source>Lung Cancer</source>
          <year>2003</year>
          <volume>41</volume>
          <issue>1</issue>
          <fpage>65</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">12826314</pub-id>
        </element-citation>
      </ref>
      <ref id="r64">
        <label>64</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>X.Z.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Cass</surname>
              <given-names>D.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin.</article-title>
          <source>J. Cell Biol.</source>
          <year>1996</year>
          <volume>133</volume>
          <issue>4</issue>
          <fpage>921</fpage>
          <lpage>928</lpage>
          <pub-id pub-id-type="pmid">8666675</pub-id>
        </element-citation>
      </ref>
      <ref id="r65">
        <label>65</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Kaminski</surname>
              <given-names>N.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema.</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>422</volume>
          <issue>6928</issue>
          <fpage>169</fpage>
          <lpage>173</lpage>
          <pub-id pub-id-type="pmid">12634787</pub-id>
        </element-citation>
      </ref>
      <ref id="r66">
        <label>66</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheppard</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Roles of alphav integrins in vascular biology and pulmonary pathology.</article-title>
          <source>Curr. Opin. Cell Biol.</source>
          <year>2004</year>
          <volume>16</volume>
          <issue>5</issue>
          <fpage>552</fpage>
          <lpage>557</lpage>
          <pub-id pub-id-type="pmid">15363806</pub-id>
        </element-citation>
      </ref>
      <ref id="r67">
        <label>67</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wipff</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Rifkin</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Meister</surname>
              <given-names>J.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix.</article-title>
          <source>J. Cell Biol.</source>
          <year>2007</year>
          <volume>179</volume>
          <issue>6</issue>
          <fpage>1311</fpage>
          <lpage>1323</lpage>
          <pub-id pub-id-type="pmid">18086923</pub-id>
        </element-citation>
      </ref>
      <ref id="r68">
        <label>68</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horan</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ona</surname>
              <given-names>V.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.</article-title>
          <source>Am. J. Respir. Crit. Care Med.</source>
          <year>2008</year>
          <volume>177</volume>
          <issue>1</issue>
          <fpage>56</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">17916809</pub-id>
        </element-citation>
      </ref>
      <ref id="r69">
        <label>69</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>John</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Luckett</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Tatler</surname>
              <given-names>A.L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Preclinical SPECT/CT imaging of &#x3B1;v&#x3B2;6 integrins for molecular stratification of idiopathic pulmonary fibrosis.</article-title>
          <source>J. Nucl. Med.</source>
          <year>2013</year>
          <volume>54</volume>
          <issue>12</issue>
          <fpage>2146</fpage>
          <lpage>2152</lpage>
          <pub-id pub-id-type="pmid">24167080</pub-id>
        </element-citation>
      </ref>
      <ref id="r70">
        <label>70</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jenkins</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>G.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.</article-title>
          <source>J. Clin. Invest.</source>
          <year>2006</year>
          <volume>116</volume>
          <issue>6</issue>
          <fpage>1606</fpage>
          <lpage>1614</lpage>
          <pub-id pub-id-type="pmid">16710477</pub-id>
        </element-citation>
      </ref>
      <ref id="r71">
        <label>71</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>M.Y.</given-names>
            </name>
            <name>
              <surname>Porte</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Knox</surname>
              <given-names>A.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation <italic>via</italic> the LPA2 receptor and the small G protein G alpha(q).</article-title>
          <source>Am. J. Pathol.</source>
          <year>2009</year>
          <volume>174</volume>
          <issue>4</issue>
          <fpage>1264</fpage>
          <lpage>1279</lpage>
          <pub-id pub-id-type="pmid">19147812</pub-id>
        </element-citation>
      </ref>
      <ref id="r72">
        <label>72</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jolly</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Stavrou</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Vanderstoken</surname>
              <given-names>G.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Influenza promotes collagen deposition <italic>via</italic> &#x3B1;v&#x3B2;6 integrin-mediated transforming growth factor &#x3B2; activation.</article-title>
          <source>J. Biol. Chem.</source>
          <year>2014</year>
          <volume>289</volume>
          <issue>51</issue>
          <fpage>35246</fpage>
          <lpage>35263</lpage>
          <pub-id pub-id-type="pmid">25339175</pub-id>
        </element-citation>
      </ref>
      <ref id="r73">
        <label>73</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Konishi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>K.F.</given-names>
            </name>
            <name>
              <surname>Lindell</surname>
              <given-names>K.O.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis.</article-title>
          <source>Am. J. Respir. Crit. Care Med.</source>
          <year>2009</year>
          <volume>180</volume>
          <issue>2</issue>
          <fpage>167</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="pmid">19363140</pub-id>
        </element-citation>
      </ref>
      <ref id="r74">
        <label>74</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benayoun</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Druilhe</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dombret</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Airway structural alterations selectively associated with severe asthma.</article-title>
          <source>Am. J. Respir. Crit. Care Med.</source>
          <year>2003</year>
          <volume>167</volume>
          <issue>10</issue>
          <fpage>1360</fpage>
          <lpage>1368</lpage>
          <pub-id pub-id-type="pmid">12531777</pub-id>
        </element-citation>
      </ref>
      <ref id="r75">
        <label>75</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tran</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Teoh</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Tam</surname>
              <given-names>J.K.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Laminin drives survival signals to promote a contractile smooth muscle phenotype and airway hyperreactivity.</article-title>
          <source>FASEB J.</source>
          <year>2013</year>
          <volume>27</volume>
          <issue>10</issue>
          <fpage>3991</fpage>
          <lpage>4003</lpage>
          <pub-id pub-id-type="pmid">23756649</pub-id>
        </element-citation>
      </ref>
      <ref id="r76">
        <label>76</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lambert</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Wiggs</surname>
              <given-names>B.R.</given-names>
            </name>
            <name>
              <surname>Kuwano</surname>
              <given-names>K.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional significance of increased airway smooth muscle in asthma and COPD.</article-title>
          <source>J. Appl. Physiol.</source>
          <year>1993</year>
          <volume>74</volume>
          <issue>6</issue>
          <fpage>2771</fpage>
          <lpage>2781</lpage>
          <pub-id pub-id-type="pmid">8365980</pub-id>
        </element-citation>
      </ref>
      <ref id="r77">
        <label>77</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christie</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Jonas</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>C.H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone.</article-title>
          <source>Eur. Respir. J.</source>
          <year>2004</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>107</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="pmid">15293612</pub-id>
        </element-citation>
      </ref>
      <ref id="r78">
        <label>78</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rihs</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Virchow</surname>
              <given-names>J.C.</given-names>
              <suffix>Jr</suffix>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta.</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>1996</year>
          <volume>15</volume>
          <issue>5</issue>
          <fpage>600</fpage>
          <lpage>610</lpage>
          <pub-id pub-id-type="pmid">8918367</pub-id>
        </element-citation>
      </ref>
      <ref id="r79">
        <label>79</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leckie</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>G.R.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+).</article-title>
          <source>Thorax</source>
          <year>2003</year>
          <volume>58</volume>
          <issue>1</issue>
          <fpage>23</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">12511714</pub-id>
        </element-citation>
      </ref>
      <ref id="r80">
        <label>80</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lawler</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>The functions of thrombospondin-1 and-2.</article-title>
          <source>Curr. Opin. Cell Biol.</source>
          <year>2000</year>
          <volume>12</volume>
          <issue>5</issue>
          <fpage>634</fpage>
          <lpage>640</lpage>
          <pub-id pub-id-type="pmid">10978901</pub-id>
        </element-citation>
      </ref>
      <ref id="r81">
        <label>81</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lawler</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sunday</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Thibert</surname>
              <given-names>V.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.</article-title>
          <source>J. Clin. Invest.</source>
          <year>1998</year>
          <volume>101</volume>
          <issue>5</issue>
          <fpage>982</fpage>
          <lpage>992</lpage>
          <pub-id pub-id-type="pmid">9486968</pub-id>
        </element-citation>
      </ref>
      <ref id="r82">
        <label>82</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yabkowitz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Dixit</surname>
              <given-names>V.M.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>N.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activated T-cell adhesion to thrombospondin is mediated by the alpha 4 beta 1 (VLA-4) and alpha 5 beta 1 (VLA-5) integrins.</article-title>
          <source>J. Immunol.</source>
          <year>1993</year>
          <volume>151</volume>
          <issue>1</issue>
          <fpage>149</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="pmid">8100842</pub-id>
        </element-citation>
      </ref>
      <ref id="r83">
        <label>83</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mansfield</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Boxer</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Suchard</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Thrombospondin stimulates motility of human neutrophils.</article-title>
          <source>J. Cell Biol.</source>
          <year>1990</year>
          <volume>111</volume>
          <issue>6 Pt 2</issue>
          <fpage>3077</fpage>
          <lpage>3086</lpage>
          <pub-id pub-id-type="pmid">2269666</pub-id>
        </element-citation>
      </ref>
      <ref id="r84">
        <label>84</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mansfield</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Suchard</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes.</article-title>
          <source>J. Immunol.</source>
          <year>1994</year>
          <volume>153</volume>
          <issue>9</issue>
          <fpage>4219</fpage>
          <lpage>4229</lpage>
          <pub-id pub-id-type="pmid">7930624</pub-id>
        </element-citation>
      </ref>
      <ref id="r85">
        <label>85</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huber</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Ellis</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>K.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Monocyte diapedesis through an <italic>in vitro</italic> vessel wall construct: inhibition with monoclonal antibodies to thrombospondin.</article-title>
          <source>J. Leukoc. Biol.</source>
          <year>1992</year>
          <volume>52</volume>
          <issue>5</issue>
          <fpage>524</fpage>
          <lpage>528</lpage>
          <pub-id pub-id-type="pmid">1431563</pub-id>
        </element-citation>
      </ref>
      <ref id="r86">
        <label>86</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Templeton</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Al-Barazi</surname>
              <given-names>H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thrombospondin-1 promotes alpha3beta1 integrin-mediated adhesion and neurite-like outgrowth and inhibits proliferation of small cell lung carcinoma cells.</article-title>
          <source>Cancer Res.</source>
          <year>2000</year>
          <volume>60</volume>
          <issue>2</issue>
          <fpage>457</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="pmid">10667601</pub-id>
        </element-citation>
      </ref>
      <ref id="r87">
        <label>87</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ezzie</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Piper</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Montague</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thrombospondin-1-deficient mice are not protected from bleomycin-induced pulmonary fibrosis.</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>2011</year>
          <volume>44</volume>
          <issue>4</issue>
          <fpage>556</fpage>
          <lpage>561</lpage>
          <pub-id pub-id-type="pmid">20581099</pub-id>
        </element-citation>
      </ref>
      <ref id="r88">
        <label>88</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheppard</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis.</article-title>
          <source>Proc. Am. Thorac. Soc.</source>
          <year>2006</year>
          <volume>3</volume>
          <issue>5</issue>
          <fpage>413</fpage>
          <lpage>417</lpage>
          <pub-id pub-id-type="pmid">16799084</pub-id>
        </element-citation>
      </ref>
      <ref id="r89">
        <label>89</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munger</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Kawakatsu</surname>
              <given-names>H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.</article-title>
          <source>Cell</source>
          <year>1999</year>
          <volume>96</volume>
          <issue>3</issue>
          <fpage>319</fpage>
          <lpage>328</lpage>
          <pub-id pub-id-type="pmid">10025398</pub-id>
        </element-citation>
      </ref>
      <ref id="r90">
        <label>90</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clark</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Sage</surname>
              <given-names>E.H.</given-names>
            </name>
          </person-group>
          <article-title>A prototypic matricellular protein in the tumor microenvironment--where there's SPARC, there's fire.</article-title>
          <source>J. Cell. Biochem.</source>
          <year>2008</year>
          <volume>104</volume>
          <issue>3</issue>
          <fpage>721</fpage>
          <lpage>732</lpage>
          <pub-id pub-id-type="pmid">18253934</pub-id>
        </element-citation>
      </ref>
      <ref id="r91">
        <label>91</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuhn</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Mason</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis.</article-title>
          <source>Am. J. Pathol.</source>
          <year>1995</year>
          <volume>147</volume>
          <issue>6</issue>
          <fpage>1759</fpage>
          <lpage>1769</lpage>
          <pub-id pub-id-type="pmid">7495300</pub-id>
        </element-citation>
      </ref>
      <ref id="r92">
        <label>92</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sage</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Vernon</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Funk</surname>
              <given-names>S.E.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading <italic>in vitro</italic> and exhibits Ca+2-dependent binding to the extracellular matrix.</article-title>
          <source>J. Cell Biol.</source>
          <year>1989</year>
          <volume>109</volume>
          <issue>1</issue>
          <fpage>341</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="pmid">2745554</pub-id>
        </element-citation>
      </ref>
      <ref id="r93">
        <label>93</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francki</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bradshaw</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Bassuk</surname>
              <given-names>J.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells.</article-title>
          <source>J. Biol. Chem.</source>
          <year>1999</year>
          <volume>274</volume>
          <issue>45</issue>
          <fpage>32145</fpage>
          <lpage>32152</lpage>
          <pub-id pub-id-type="pmid">10542250</pub-id>
        </element-citation>
      </ref>
      <ref id="r94">
        <label>94</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gruber</surname>
              <given-names>H.E.</given-names>
            </name>
            <name>
              <surname>Sage</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Norton</surname>
              <given-names>H.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeted deletion of the SPARC gene accelerates disc degeneration in the aging mouse.</article-title>
          <source>J. Histochem. Cytochem.</source>
          <year>2005</year>
          <volume>53</volume>
          <issue>9</issue>
          <fpage>1131</fpage>
          <lpage>1138</lpage>
          <pub-id pub-id-type="pmid">15879573</pub-id>
        </element-citation>
      </ref>
      <ref id="r95">
        <label>95</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bradshaw</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Puolakkainen</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Dasgupta</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength.</article-title>
          <source>J. Invest. Dermatol.</source>
          <year>2003</year>
          <volume>120</volume>
          <issue>6</issue>
          <fpage>949</fpage>
          <lpage>955</lpage>
          <pub-id pub-id-type="pmid">12787119</pub-id>
        </element-citation>
      </ref>
      <ref id="r96">
        <label>96</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barker</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Baneyx</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Card&#xF3;-Vila</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity.</article-title>
          <source>J. Biol. Chem.</source>
          <year>2005</year>
          <volume>280</volume>
          <issue>43</issue>
          <fpage>36483</fpage>
          <lpage>36493</lpage>
          <pub-id pub-id-type="pmid">16115889</pub-id>
        </element-citation>
      </ref>
      <ref id="r97">
        <label>97</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>S.S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin.</article-title>
          <source>J. Biol. Chem.</source>
          <year>2010</year>
          <volume>285</volume>
          <issue>11</issue>
          <fpage>8196</fpage>
          <lpage>8206</lpage>
          <pub-id pub-id-type="pmid">20061390</pub-id>
        </element-citation>
      </ref>
      <ref id="r98">
        <label>98</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takayama</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Arima</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kanaji</surname>
              <given-names>T.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.</article-title>
          <source>J. Allergy Clin. Immunol.</source>
          <year>2006</year>
          <volume>118</volume>
          <issue>1</issue>
          <fpage>98</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">16815144</pub-id>
        </element-citation>
      </ref>
      <ref id="r99">
        <label>99</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blanchard</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Mingler</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>McBride</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses.</article-title>
          <source>Mucosal Immunol.</source>
          <year>2008</year>
          <volume>1</volume>
          <issue>4</issue>
          <fpage>289</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">19079190</pub-id>
        </element-citation>
      </ref>
      <ref id="r100">
        <label>100</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gillan</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Matei</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>D.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.</article-title>
          <source>Cancer Res.</source>
          <year>2002</year>
          <volume>62</volume>
          <issue>18</issue>
          <fpage>5358</fpage>
          <lpage>5364</lpage>
          <pub-id pub-id-type="pmid">12235007</pub-id>
        </element-citation>
      </ref>
      <ref id="r101">
        <label>101</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sehra</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>E.T.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation.</article-title>
          <source>J. Immunol.</source>
          <year>2011</year>
          <volume>186</volume>
          <issue>8</issue>
          <fpage>4959</fpage>
          <lpage>4966</lpage>
          <pub-id pub-id-type="pmid">21402898</pub-id>
        </element-citation>
      </ref>
      <ref id="r102">
        <label>102</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thai</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Loukoianov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wachi</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regulation of airway mucin gene expression.</article-title>
          <source>Annu. Rev. Physiol.</source>
          <year>2008</year>
          <volume>70</volume>
          <fpage>405</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="pmid">17961085</pub-id>
        </element-citation>
      </ref>
      <ref id="r103">
        <label>103</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ouyang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>K.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival <italic>via</italic> the Akt/PKB pathway.</article-title>
          <source>Cancer Lett.</source>
          <year>2009</year>
          <volume>281</volume>
          <issue>2</issue>
          <fpage>213</fpage>
          <lpage>219</lpage>
          <pub-id pub-id-type="pmid">19328625</pub-id>
        </element-citation>
      </ref>
      <ref id="r104">
        <label>104</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bao</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ouyang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>X.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival <italic>via</italic> the Akt/PKB pathway.</article-title>
          <source>Cancer Cell</source>
          <year>2004</year>
          <volume>5</volume>
          <issue>4</issue>
          <fpage>329</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="pmid">15093540</pub-id>
        </element-citation>
      </ref>
      <ref id="r105">
        <label>105</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naik</surname>
              <given-names>P.K.</given-names>
            </name>
            <name>
              <surname>Bozyk</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>Bentley</surname>
              <given-names>J.K.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.</article-title>
          <source>Am. J. Physiol. Lung Cell. Mol. Physiol.</source>
          <year>2012</year>
          <volume>303</volume>
          <issue>12</issue>
          <fpage>L1046</fpage>
          <lpage>L1056</lpage>
          <pub-id pub-id-type="pmid">23043074</pub-id>
        </element-citation>
      </ref>
      <ref id="r106">
        <label>106</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okamoto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hoshino</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kitasato</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias.</article-title>
          <source>Eur. Respir. J.</source>
          <year>2011</year>
          <volume>37</volume>
          <issue>5</issue>
          <fpage>1119</fpage>
          <lpage>1127</lpage>
          <pub-id pub-id-type="pmid">21177844</pub-id>
        </element-citation>
      </ref>
      <ref id="r107">
        <label>107</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uchida</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shiraishi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ohta</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis.</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>2012</year>
          <volume>46</volume>
          <issue>5</issue>
          <fpage>677</fpage>
          <lpage>686</lpage>
          <pub-id pub-id-type="pmid">22246863</pub-id>
        </element-citation>
      </ref>
      <ref id="r108">
        <label>108</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pozzi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Moberg</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Miles</surname>
              <given-names>L.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2000</year>
          <volume>97</volume>
          <issue>5</issue>
          <fpage>2202</fpage>
          <lpage>2207</lpage>
          <pub-id pub-id-type="pmid">10681423</pub-id>
        </element-citation>
      </ref>
      <ref id="r109">
        <label>109</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kreidberg</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Donovan</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>S.L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis.</article-title>
          <source>Development</source>
          <year>1996</year>
          <volume>122</volume>
          <issue>11</issue>
          <fpage>3537</fpage>
          <lpage>3547</lpage>
          <pub-id pub-id-type="pmid">8951069</pub-id>
        </element-citation>
      </ref>
      <ref id="r110">
        <label>110</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DiPersio</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Hodivala-Dilke</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Jaenisch</surname>
              <given-names>R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>alpha3beta1 Integrin is required for normal development of the epidermal basement membrane.</article-title>
          <source>J. Cell Biol.</source>
          <year>1997</year>
          <volume>137</volume>
          <issue>3</issue>
          <fpage>729</fpage>
          <lpage>742</lpage>
          <pub-id pub-id-type="pmid">9151677</pub-id>
        </element-citation>
      </ref>
      <ref id="r111">
        <label>111</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anton</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Kreidberg</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Rakic</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Distinct functions of alpha3 and alpha(v) integrin receptors in neuronal migration and laminar organization of the cerebral cortex.</article-title>
          <source>Neuron</source>
          <year>1999</year>
          <volume>22</volume>
          <issue>2</issue>
          <fpage>277</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">10069334</pub-id>
        </element-citation>
      </ref>
      <ref id="r112">
        <label>112</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Georges-Labouesse</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Mark</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Messaddeq</surname>
              <given-names>N.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Essential role of alpha 6 integrins in cortical and retinal lamination.</article-title>
          <source>Curr. Biol.</source>
          <year>1998</year>
          <volume>8</volume>
          <issue>17</issue>
          <fpage>983</fpage>
          <lpage>986</lpage>
          <pub-id pub-id-type="pmid">9742403</pub-id>
        </element-citation>
      </ref>
      <ref id="r113">
        <label>113</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Arcangelis</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mark</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kreidberg</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Synergistic activities of alpha3 and alpha6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse.</article-title>
          <source>Development</source>
          <year>1999</year>
          <volume>126</volume>
          <issue>17</issue>
          <fpage>3957</fpage>
          <lpage>3968</lpage>
          <pub-id pub-id-type="pmid">10433923</pub-id>
        </element-citation>
      </ref>
      <ref id="r114">
        <label>114</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>X.Z.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Ferrando</surname>
              <given-names>R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1.</article-title>
          <source>Mol. Cell. Biol.</source>
          <year>2000</year>
          <volume>20</volume>
          <issue>14</issue>
          <fpage>5208</fpage>
          <lpage>5215</lpage>
          <pub-id pub-id-type="pmid">10866676</pub-id>
        </element-citation>
      </ref>
      <ref id="r115">
        <label>115</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hodnett</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>N.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrin alphavbeta5 regulates lung vascular permeability and pulmonary endothelial barrier function.</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>2007</year>
          <volume>36</volume>
          <issue>3</issue>
          <fpage>377</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="pmid">17079779</pub-id>
        </element-citation>
      </ref>
      <ref id="r116">
        <label>116</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kikuchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tachimoto</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nutku</surname>
              <given-names>E.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phorbol esters alter alpha4 and alphad integrin usage during eosinophil adhesion to VCAM-1.</article-title>
          <source>Cell Commun. Adhes.</source>
          <year>2003</year>
          <volume>10</volume>
          <issue>3</issue>
          <fpage>119</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="pmid">14668059</pub-id>
        </element-citation>
      </ref>
      <ref id="r117">
        <label>117</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bayless</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Meininger</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Scholtz</surname>
              <given-names>J.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Osteopontin is a ligand for the alpha4beta1 integrin.</article-title>
          <source>J. Cell Sci.</source>
          <year>1998</year>
          <volume>111</volume>
          <issue>Pt 9</issue>
          <fpage>1165</fpage>
          <lpage>1174</lpage>
          <pub-id pub-id-type="pmid">9547293</pub-id>
        </element-citation>
      </ref>
      <ref id="r118">
        <label>118</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bocchino</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Bertorelli</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>D'Ippolito</surname>
              <given-names>R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The increased number of very late activation antigen-4-positive cells correlates with eosinophils and severity of disease in the induced sputum of asthmatic patients.</article-title>
          <source>J. Allergy Clin. Immunol.</source>
          <year>2000</year>
          <volume>105</volume>
          <issue>1 Pt 1</issue>
          <fpage>65</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">10629454</pub-id>
        </element-citation>
      </ref>
      <ref id="r119">
        <label>119</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cox</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Moran</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Integrins as therapeutic targets: lessons and opportunities.</article-title>
          <source>Nat. Rev. Drug Discov.</source>
          <year>2013</year>
          <volume>9</volume>
          <issue>10</issue>
          <fpage>804</fpage>
          <lpage>820</lpage>
        </element-citation>
      </ref>
      <ref id="r120">
        <label>120</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Norris</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Choong</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>D.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.</article-title>
          <source>J. Allergy Clin. Immunol.</source>
          <year>2005</year>
          <volume>116</volume>
          <issue>4</issue>
          <fpage>761</fpage>
          <lpage>767</lpage>
          <pub-id pub-id-type="pmid">16210048</pub-id>
        </element-citation>
      </ref>
      <ref id="r121">
        <label>121</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Wicks</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Powell</surname>
              <given-names>R.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Airway remodeling in asthma: new insights.</article-title>
          <source>J. Allergy Clin. Immunol.</source>
          <year>2003</year>
          <volume>111</volume>
          <issue>2</issue>
          <fpage>215</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="pmid">12589337</pub-id>
        </element-citation>
      </ref>
      <ref id="r122">
        <label>122</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMillan</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Xanthou</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Lloyd</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway.</article-title>
          <source>J. Immunol.</source>
          <year>2005</year>
          <volume>174</volume>
          <issue>9</issue>
          <fpage>5774</fpage>
          <lpage>5780</lpage>
          <pub-id pub-id-type="pmid">15843580</pub-id>
        </element-citation>
      </ref>
      <ref id="r123">
        <label>123</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Churg</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling.</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>2009</year>
          <volume>40</volume>
          <issue>4</issue>
          <fpage>482</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="pmid">18931327</pub-id>
        </element-citation>
      </ref>
      <ref id="r124">
        <label>124</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Podowski</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Calvi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Metzger</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice.</article-title>
          <source>J. Clin. Invest.</source>
          <year>2012</year>
          <volume>122</volume>
          <issue>1</issue>
          <fpage>229</fpage>
          <lpage>240</lpage>
          <pub-id pub-id-type="pmid">22182843</pub-id>
        </element-citation>
      </ref>
      <ref id="r125">
        <label>125</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitamura</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Cambier</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Somanath</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin &#x3B1;v&#x3B2;8-mediated activation of TGF-&#x3B2;.</article-title>
          <source>J. Clin. Invest.</source>
          <year>2011</year>
          <volume>121</volume>
          <issue>7</issue>
          <fpage>2863</fpage>
          <lpage>2875</lpage>
          <pub-id pub-id-type="pmid">21646718</pub-id>
        </element-citation>
      </ref>
      <ref id="r126">
        <label>126</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Chui</surname>
              <given-names>W.K.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>P.C.</given-names>
            </name>
          </person-group>
          <article-title>Integrin targeted drug and gene delivery.</article-title>
          <source>Expert Opin. Drug Deliv.</source>
          <year>2010</year>
          <volume>7</volume>
          <issue>2</issue>
          <fpage>159</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="pmid">20095940</pub-id>
        </element-citation>
      </ref>
      <ref id="r127">
        <label>127</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ellerby</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Arap</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ellerby</surname>
              <given-names>L.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Anti-cancer activity of targeted pro-apoptotic peptides.</article-title>
          <source>Nat. Med.</source>
          <year>1999</year>
          <volume>5</volume>
          <issue>9</issue>
          <fpage>1032</fpage>
          <lpage>1038</lpage>
          <pub-id pub-id-type="pmid">10470080</pub-id>
        </element-citation>
      </ref>
      <ref id="r128">
        <label>128</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reardon</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Neyns</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Weller</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cilengitide: an RGD pentapeptide &#x3B1;&#x3BD;&#x3B2;3 and &#x3B1;&#x3BD;&#x3B2;5 integrin inhibitor in development for glioblastoma and other malignancies.</article-title>
          <source>Future Oncol.</source>
          <year>2011</year>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>339</fpage>
          <lpage>354</lpage>
          <pub-id pub-id-type="pmid">21417900</pub-id>
        </element-citation>
      </ref>
      <ref id="r129">
        <label>129</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuwada</surname>
              <given-names>S.K.</given-names>
            </name>
          </person-group>
          <article-title>Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody.</article-title>
          <source>Curr. Opin. Mol. Ther.</source>
          <year>2007</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>92</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">17330407</pub-id>
        </element-citation>
      </ref>
      <ref id="r130">
        <label>130</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francis</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Goh</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Hodivala-Dilke</surname>
              <given-names>K.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies.</article-title>
          <source>Arterioscler. Thromb. Vasc. Biol.</source>
          <year>2002</year>
          <volume>22</volume>
          <issue>6</issue>
          <fpage>927</fpage>
          <lpage>933</lpage>
          <pub-id pub-id-type="pmid">12067900</pub-id>
        </element-citation>
      </ref>
      <ref id="r131">
        <label>131</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sudhakar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sugimoto</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2003</year>
          <volume>100</volume>
          <issue>8</issue>
          <fpage>4766</fpage>
          <lpage>4771</lpage>
          <pub-id pub-id-type="pmid">12682293</pub-id>
        </element-citation>
      </ref>
      <ref id="r132">
        <label>132</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pedchenko</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Zent</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hudson</surname>
              <given-names>B.G.</given-names>
            </name>
          </person-group>
          <article-title>Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion.</article-title>
          <source>J. Biol. Chem.</source>
          <year>2004</year>
          <volume>279</volume>
          <issue>4</issue>
          <fpage>2772</fpage>
          <lpage>2780</lpage>
          <pub-id pub-id-type="pmid">14610079</pub-id>
        </element-citation>
      </ref>
      <ref id="r133">
        <label>133</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marneros</surname>
              <given-names>A.G.</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>B.R.</given-names>
            </name>
          </person-group>
          <article-title>The role of collagen-derived proteolytic fragments in angiogenesis.</article-title>
          <source>Matrix Biol.</source>
          <year>2001</year>
          <volume>20</volume>
          <issue>5-6</issue>
          <fpage>337</fpage>
          <lpage>345</lpage>
          <pub-id pub-id-type="pmid">11566268</pub-id>
        </element-citation>
      </ref>
      <ref id="r134">
        <label>134</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcinkiewicz</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Weinreb</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Calvete</surname>
              <given-names>J.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Obtustatin: a potent selective inhibitor of alpha1beta1 integrin <italic>in vitro</italic> and angiogenesis <italic>in vivo.</italic></article-title>
          <source>Cancer Res.</source>
          <year>2003</year>
          <volume>63</volume>
          <issue>9</issue>
          <fpage>2020</fpage>
          <lpage>2023</lpage>
          <pub-id pub-id-type="pmid">12727812</pub-id>
        </element-citation>
      </ref>
      <ref id="r135">
        <label>135</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Lozano</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fibulin-5/DANCE is essential for elastogenesis <italic>in vivo.</italic></article-title>
          <source>Nature</source>
          <year>2002</year>
          <volume>415</volume>
          <issue>6868</issue>
          <fpage>171</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="pmid">11805835</pub-id>
        </element-citation>
      </ref>
      <ref id="r136">
        <label>136</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Dorscheid</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Rabe</surname>
              <given-names>K.F.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of very late adhesion integrins in mediating repair of human airway epithelial cell monolayers after mechanical injury.</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <year>1999</year>
          <volume>20</volume>
          <issue>4</issue>
          <fpage>787</fpage>
          <lpage>796</lpage>
          <pub-id pub-id-type="pmid">10101012</pub-id>
        </element-citation>
      </ref>
      <ref id="r137">
        <label>137</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adachi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Taki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Higashiyama</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer.</article-title>
          <source>Clin. Cancer Res.</source>
          <year>2000</year>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>96</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="pmid">10656437</pub-id>
        </element-citation>
      </ref>
      <ref id="r138">
        <label>138</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caccavari</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Valdembri</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Sandri</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrin signaling and lung cancer.</article-title>
          <source>Cell Adhes. Migr.</source>
          <year>2010</year>
          <volume>4</volume>
          <issue>1</issue>
          <fpage>124</fpage>
          <lpage>129</lpage>
        </element-citation>
      </ref>
      <ref id="r139">
        <label>139</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Z.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The expression of integrin alpha5beta1 and transforming growth factor-beta in pulmonary fibrosis of rat.</article-title>
          <source>Zhonghua Bing Li Xue Za Zhi</source>
          <year>1999</year>
          <volume>28</volume>
          <issue>6</issue>
          <fpage>427</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="pmid">11869556</pub-id>
        </element-citation>
      </ref>
      <ref id="r140">
        <label>140</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saltini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hemler</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Crystal</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1.</article-title>
          <source>Clin. Immunol. Immunopathol.</source>
          <year>1988</year>
          <volume>46</volume>
          <issue>2</issue>
          <fpage>221</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="pmid">3257425</pub-id>
        </element-citation>
      </ref>
      <ref id="r141">
        <label>141</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gardner</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kreidberg</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Koteliansky</surname>
              <given-names>V.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion.</article-title>
          <source>Dev. Biol.</source>
          <year>1996</year>
          <volume>175</volume>
          <issue>2</issue>
          <fpage>301</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="pmid">8626034</pub-id>
        </element-citation>
      </ref>
      <ref id="r142">
        <label>142</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pozzi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wary</surname>
              <given-names>K.K.</given-names>
            </name>
            <name>
              <surname>Giancotti</surname>
              <given-names>F.G.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrin alpha1beta1 mediates a unique collagen-dependent proliferation pathway <italic>in vivo.</italic></article-title>
          <source>J. Cell Biol.</source>
          <year>1998</year>
          <volume>142</volume>
          <issue>2</issue>
          <fpage>587</fpage>
          <lpage>594</lpage>
          <pub-id pub-id-type="pmid">9679154</pub-id>
        </element-citation>
      </ref>
      <ref id="r143">
        <label>143</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gardner</surname>
              <given-names>H.A.</given-names>
            </name>
          </person-group>
          <article-title>Integrin signaling in fibrosis and scleroderma.</article-title>
          <source>Curr. Rheumatol. Rep.</source>
          <year>1999</year>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>28</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">11123011</pub-id>
        </element-citation>
      </ref>
      <ref id="r144">
        <label>144</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holtkotter</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Nieswandt</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Smyth</surname>
              <given-names>N.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen.</article-title>
          <source>J. Biol. Chem.</source>
          <year>2002</year>
          <volume>277</volume>
          <issue>13</issue>
          <fpage>10789</fpage>
          <lpage>10794</lpage>
          <pub-id pub-id-type="pmid">11788609</pub-id>
        </element-citation>
      </ref>
      <ref id="r145">
        <label>145</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Diacovo</surname>
              <given-names>T.G.</given-names>
            </name>
            <name>
              <surname>Grenache</surname>
              <given-names>D.G.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis.</article-title>
          <source>Am. J. Pathol.</source>
          <year>2002</year>
          <volume>161</volume>
          <issue>1</issue>
          <fpage>337</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="pmid">12107118</pub-id>
        </element-citation>
      </ref>
      <ref id="r146">
        <label>146</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edelson</surname>
              <given-names>B.T.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Pappan</surname>
              <given-names>L.K.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mast cell-mediated inflammatory responses require the alpha 2 beta 1 integrin.</article-title>
          <source>Blood</source>
          <year>2004</year>
          <volume>103</volume>
          <issue>6</issue>
          <fpage>2214</fpage>
          <lpage>2220</lpage>
          <pub-id pub-id-type="pmid">14645004</pub-id>
        </element-citation>
      </ref>
      <ref id="r147">
        <label>147</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCall-Culbreath</surname>
              <given-names>K.D.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zutter</surname>
              <given-names>M.M.</given-names>
            </name>
          </person-group>
          <article-title>Crosstalk between the alpha2beta1 integrin and c-met/HGF-R regulates innate immunity.</article-title>
          <source>Blood</source>
          <year>2008</year>
          <volume>111</volume>
          <issue>7</issue>
          <fpage>3562</fpage>
          <lpage>3570</lpage>
          <pub-id pub-id-type="pmid">18198349</pub-id>
        </element-citation>
      </ref>
      <ref id="r148">
        <label>148</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Menko</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Kreidberg</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>T.T.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss of alpha3beta1 integrin function results in an altered differentiation program in the mouse submandibular gland.</article-title>
          <source>Dev. Dyn.</source>
          <year>2001</year>
          <volume>220</volume>
          <issue>4</issue>
          <fpage>337</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="pmid">11307167</pub-id>
        </element-citation>
      </ref>
      <ref id="r149">
        <label>149</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Rayburn</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hynes</surname>
              <given-names>R.O.</given-names>
            </name>
          </person-group>
          <article-title>Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development.</article-title>
          <source>Development</source>
          <year>1995</year>
          <volume>121</volume>
          <issue>2</issue>
          <fpage>549</fpage>
          <lpage>560</lpage>
          <pub-id pub-id-type="pmid">7539359</pub-id>
        </element-citation>
      </ref>
      <ref id="r150">
        <label>150</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arroyo</surname>
              <given-names>A.G.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Rayburn</surname>
              <given-names>H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential requirements for alpha4 integrins during fetal and adult hematopoiesis.</article-title>
          <source>Cell</source>
          <year>1996</year>
          <volume>85</volume>
          <issue>7</issue>
          <fpage>997</fpage>
          <lpage>1008</lpage>
          <pub-id pub-id-type="pmid">8674127</pub-id>
        </element-citation>
      </ref>
      <ref id="r151">
        <label>151</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arroyo</surname>
              <given-names>A.G.</given-names>
            </name>
            <name>
              <surname>Taverna</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Whittaker</surname>
              <given-names>C.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>
<italic>In vivo</italic> roles of integrins during leukocyte development and traffic: insights from the analysis of mice chimeric for alpha 5, alpha v, and alpha 4 integrins.</article-title>
          <source>J. Immunol.</source>
          <year>2000</year>
          <volume>165</volume>
          <issue>8</issue>
          <fpage>4667</fpage>
          <lpage>4675</lpage>
          <pub-id pub-id-type="pmid">11035110</pub-id>
        </element-citation>
      </ref>
      <ref id="r152">
        <label>152</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Rayburn</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hynes</surname>
              <given-names>R.O.</given-names>
            </name>
          </person-group>
          <article-title>Embryonic mesodermal defects in alpha 5 integrin-deficient mice.</article-title>
          <source>Development</source>
          <year>1993</year>
          <volume>119</volume>
          <issue>4</issue>
          <fpage>1093</fpage>
          <lpage>1105</lpage>
          <pub-id pub-id-type="pmid">7508365</pub-id>
        </element-citation>
      </ref>
      <ref id="r153">
        <label>153</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Bader</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Kreidberg</surname>
              <given-names>J.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Overlapping and independent functions of fibronectin receptor integrins in early mesodermal development.</article-title>
          <source>Dev. Biol.</source>
          <year>1999</year>
          <volume>215</volume>
          <issue>2</issue>
          <fpage>264</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="pmid">10545236</pub-id>
        </element-citation>
      </ref>
      <ref id="r154">
        <label>154</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goh</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Hynes</surname>
              <given-names>R.O.</given-names>
            </name>
          </person-group>
          <article-title>Mesodermal defects and cranial neural crest apoptosis in alpha5 integrin-null embryos.</article-title>
          <source>Development</source>
          <year>1997</year>
          <volume>124</volume>
          <issue>21</issue>
          <fpage>4309</fpage>
          <lpage>4319</lpage>
          <pub-id pub-id-type="pmid">9334279</pub-id>
        </element-citation>
      </ref>
      <ref id="r155">
        <label>155</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miner</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Defective glomerulogenesis in the absence of laminin alpha5 demonstrates a developmental role for the kidney glomerular basement membrane.</article-title>
          <source>Dev. Biol.</source>
          <year>2000</year>
          <volume>217</volume>
          <issue>2</issue>
          <fpage>278</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">10625553</pub-id>
        </element-citation>
      </ref>
      <ref id="r156">
        <label>156</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayer</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Saher</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Fassler</surname>
              <given-names>R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Absence of integrin alpha 7 causes a novel form of muscular dystrophy.</article-title>
          <source>Nat. Genet.</source>
          <year>1997</year>
          <volume>17</volume>
          <issue>3</issue>
          <fpage>318</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="pmid">9354797</pub-id>
        </element-citation>
      </ref>
      <ref id="r157">
        <label>157</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayashi</surname>
              <given-names>Y.K.</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Engvall</surname>
              <given-names>E.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the integrin alpha7 gene cause congenital myopathy.</article-title>
          <source>Nat. Genet.</source>
          <year>1998</year>
          <volume>19</volume>
          <issue>1</issue>
          <fpage>94</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">9590299</pub-id>
        </element-citation>
      </ref>
      <ref id="r158">
        <label>158</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muller</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Denda</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrin alpha8beta1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis.</article-title>
          <source>Cell</source>
          <year>1997</year>
          <volume>88</volume>
          <issue>5</issue>
          <fpage>603</fpage>
          <lpage>613</lpage>
          <pub-id pub-id-type="pmid">9054500</pub-id>
        </element-citation>
      </ref>
      <ref id="r159">
        <label>159</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Littlewood Evans</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Stereocilia defects in the sensory hair cells of the inner ear in mice deficient in integrin alpha8beta1.</article-title>
          <source>Nat. Genet.</source>
          <year>2000</year>
          <volume>24</volume>
          <issue>4</issue>
          <fpage>424</fpage>
          <lpage>428</lpage>
          <pub-id pub-id-type="pmid">10742111</pub-id>
        </element-citation>
      </ref>
      <ref id="r160">
        <label>160</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bader</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Rayburn</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Crowley</surname>
              <given-names>D.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins.</article-title>
          <source>Cell</source>
          <year>1998</year>
          <volume>95</volume>
          <issue>4</issue>
          <fpage>507</fpage>
          <lpage>519</lpage>
          <pub-id pub-id-type="pmid">9827803</pub-id>
        </element-citation>
      </ref>
      <ref id="r161">
        <label>161</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henderson</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Arnold</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Katamura</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeting of &#x3B1;v integrin identifies a core molecular pathway that regulates fibrosis in several organs.</article-title>
          <source>Nat. Med.</source>
          <year>2013</year>
          <volume>19</volume>
          <issue>12</issue>
          <fpage>1617</fpage>
          <lpage>1624</lpage>
          <pub-id pub-id-type="pmid">24216753</pub-id>
        </element-citation>
      </ref>
      <ref id="r162">
        <label>162</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmits</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kundig</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>D.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor.</article-title>
          <source>J. Exp. Med.</source>
          <year>1996</year>
          <volume>183</volume>
          <issue>4</issue>
          <fpage>1415</fpage>
          <lpage>1426</lpage>
          <pub-id pub-id-type="pmid">8666900</pub-id>
        </element-citation>
      </ref>
      <ref id="r163">
        <label>163</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shier</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ngo</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fung-Leung</surname>
              <given-names>W.P.</given-names>
            </name>
          </person-group>
          <article-title>Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.</article-title>
          <source>J. Immunol.</source>
          <year>1999</year>
          <volume>163</volume>
          <issue>9</issue>
          <fpage>4826</fpage>
          <lpage>4832</lpage>
          <pub-id pub-id-type="pmid">10528183</pub-id>
        </element-citation>
      </ref>
      <ref id="r164">
        <label>164</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berlin-Rufenach</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Otto</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Mathies</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice.</article-title>
          <source>J. Exp. Med.</source>
          <year>1999</year>
          <volume>189</volume>
          <issue>9</issue>
          <fpage>1467</fpage>
          <lpage>1478</lpage>
          <pub-id pub-id-type="pmid">10224287</pub-id>
        </element-citation>
      </ref>
      <ref id="r165">
        <label>165</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coxon</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rieu</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Barkalow</surname>
              <given-names>F.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.</article-title>
          <source>Immunity</source>
          <year>1996</year>
          <volume>5</volume>
          <issue>6</issue>
          <fpage>653</fpage>
          <lpage>666</lpage>
          <pub-id pub-id-type="pmid">8986723</pub-id>
        </element-citation>
      </ref>
      <ref id="r166">
        <label>166</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenkranz</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Coxon</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Maurer</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice.</article-title>
          <source>J. Immunol.</source>
          <year>1998</year>
          <volume>161</volume>
          <issue>12</issue>
          <fpage>6463</fpage>
          <lpage>6467</lpage>
          <pub-id pub-id-type="pmid">9862668</pub-id>
        </element-citation>
      </ref>
      <ref id="r167">
        <label>167</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dong</surname>
              <given-names>Z.M.</given-names>
            </name>
            <name>
              <surname>Gutierrez-Ramos</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Coxon</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A new class of obesity genes encodes leukocyte adhesion receptors.</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>1997</year>
          <volume>94</volume>
          <issue>14</issue>
          <fpage>7526</fpage>
          <lpage>7530</lpage>
          <pub-id pub-id-type="pmid">9207125</pub-id>
        </element-citation>
      </ref>
      <ref id="r168">
        <label>168</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schon</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Arya</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>E.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice.</article-title>
          <source>J. Immunol.</source>
          <year>1999</year>
          <volume>162</volume>
          <issue>11</issue>
          <fpage>6641</fpage>
          <lpage>6649</lpage>
          <pub-id pub-id-type="pmid">10352281</pub-id>
        </element-citation>
      </ref>
      <ref id="r169">
        <label>169</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tronik-Le Roux</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Roullot</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Poujol</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thrombasthenic mice generated by replacement of the integrin alpha(IIb) gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment.</article-title>
          <source>Blood</source>
          <year>2000</year>
          <volume>96</volume>
          <issue>4</issue>
          <fpage>1399</fpage>
          <lpage>1408</lpage>
          <pub-id pub-id-type="pmid">10942384</pub-id>
        </element-citation>
      </ref>
      <ref id="r170">
        <label>170</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fassler</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Consequences of lack of beta 1 integrin gene expression in mice.</article-title>
          <source>Genes Dev.</source>
          <year>1995</year>
          <volume>9</volume>
          <issue>15</issue>
          <fpage>1896</fpage>
          <lpage>1908</lpage>
          <pub-id pub-id-type="pmid">7544313</pub-id>
        </element-citation>
      </ref>
      <ref id="r171">
        <label>171</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stephens</surname>
              <given-names>L.E.</given-names>
            </name>
            <name>
              <surname>Sutherland</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Klimanskaya</surname>
              <given-names>I.V.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality.</article-title>
          <source>Genes Dev.</source>
          <year>1995</year>
          <volume>9</volume>
          <issue>15</issue>
          <fpage>1883</fpage>
          <lpage>1895</lpage>
          <pub-id pub-id-type="pmid">7544312</pub-id>
        </element-citation>
      </ref>
      <ref id="r172">
        <label>172</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirsch</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Iglesias</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Potocnik</surname>
              <given-names>A.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta1 integrins.</article-title>
          <source>Nature</source>
          <year>1996</year>
          <volume>380</volume>
          <issue>6570</issue>
          <fpage>171</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="pmid">8600394</pub-id>
        </element-citation>
      </ref>
      <ref id="r173">
        <label>173</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Potocnik</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Brakebusch</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Fassler</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow.</article-title>
          <source>Immunity</source>
          <year>2000</year>
          <volume>12</volume>
          <issue>6</issue>
          <fpage>653</fpage>
          <lpage>663</lpage>
          <pub-id pub-id-type="pmid">10894165</pub-id>
        </element-citation>
      </ref>
      <ref id="r174">
        <label>174</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keller</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Shai</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Babbitt</surname>
              <given-names>C.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance.</article-title>
          <source>Am. J. Pathol.</source>
          <year>2001</year>
          <volume>158</volume>
          <issue>3</issue>
          <fpage>1079</fpage>
          <lpage>1090</lpage>
          <pub-id pub-id-type="pmid">11238056</pub-id>
        </element-citation>
      </ref>
      <ref id="r175">
        <label>175</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scharffetter-Kochanek</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>K.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spontaneous skin ulceration and defective T cell function in CD18 null mice.</article-title>
          <source>J. Exp. Med.</source>
          <year>1998</year>
          <volume>188</volume>
          <issue>1</issue>
          <fpage>119</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="pmid">9653089</pub-id>
        </element-citation>
      </ref>
      <ref id="r176">
        <label>176</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mizgerd</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Kubo</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kutkoski</surname>
              <given-names>G.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice.</article-title>
          <source>J. Exp. Med.</source>
          <year>1997</year>
          <volume>186</volume>
          <issue>8</issue>
          <fpage>1357</fpage>
          <lpage>1364</lpage>
          <pub-id pub-id-type="pmid">9334375</pub-id>
        </element-citation>
      </ref>
      <ref id="r177">
        <label>177</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneeberger</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Vu</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>LeBlanc</surname>
              <given-names>B.W.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The accumulation of dendritic cells in the lung is impaired in CD18-/- but not in ICAM-1-/- mutant mice.</article-title>
          <source>J. Immunol.</source>
          <year>2000</year>
          <volume>164</volume>
          <issue>5</issue>
          <fpage>2472</fpage>
          <lpage>2478</lpage>
          <pub-id pub-id-type="pmid">10679084</pub-id>
        </element-citation>
      </ref>
      <ref id="r178">
        <label>178</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hodivala-Dilke</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>McHugh</surname>
              <given-names>K.P.</given-names>
            </name>
            <name>
              <surname>Tsakiris</surname>
              <given-names>D.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.</article-title>
          <source>J. Clin. Invest.</source>
          <year>1999</year>
          <volume>103</volume>
          <issue>2</issue>
          <fpage>229</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="pmid">9916135</pub-id>
        </element-citation>
      </ref>
      <ref id="r179">
        <label>179</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McHugh</surname>
              <given-names>K.P.</given-names>
            </name>
            <name>
              <surname>Hodivala-Dilke</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>M.H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.</article-title>
          <source>J. Clin. Invest.</source>
          <year>2000</year>
          <volume>105</volume>
          <issue>4</issue>
          <fpage>433</fpage>
          <lpage>440</lpage>
          <pub-id pub-id-type="pmid">10683372</pub-id>
        </element-citation>
      </ref>
      <ref id="r180">
        <label>180</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmerman</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Leboy</surname>
              <given-names>P.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts.</article-title>
          <source>Dev. Biol.</source>
          <year>2000</year>
          <volume>220</volume>
          <issue>1</issue>
          <fpage>2</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">10720426</pub-id>
        </element-citation>
      </ref>
      <ref id="r181">
        <label>181</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dowling</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>Q.C.</given-names>
            </name>
            <name>
              <surname>Fuchs</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival.</article-title>
          <source>J. Cell Biol.</source>
          <year>1996</year>
          <volume>134</volume>
          <issue>2</issue>
          <fpage>559</fpage>
          <lpage>572</lpage>
          <pub-id pub-id-type="pmid">8707838</pub-id>
        </element-citation>
      </ref>
      <ref id="r182">
        <label>182</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice.</article-title>
          <source>Mol. Cell. Biol.</source>
          <year>2000</year>
          <volume>20</volume>
          <issue>3</issue>
          <fpage>755</fpage>
          <lpage>759</lpage>
          <pub-id pub-id-type="pmid">10629031</pub-id>
        </element-citation>
      </ref>
      <ref id="r183">
        <label>183</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wagner</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Lohler</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kunkel</surname>
              <given-names>E.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue.</article-title>
          <source>Nature</source>
          <year>1996</year>
          <volume>382</volume>
          <issue>6589</issue>
          <fpage>366</fpage>
          <lpage>370</lpage>
          <pub-id pub-id-type="pmid">8684468</pub-id>
        </element-citation>
      </ref>
      <ref id="r184">
        <label>184</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Motejlek</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>beta8 integrins are required for vascular morphogenesis in mouse embryos.</article-title>
          <source>Development</source>
          <year>2002</year>
          <volume>129</volume>
          <issue>12</issue>
          <fpage>2891</fpage>
          <lpage>2903</lpage>
          <pub-id pub-id-type="pmid">12050137</pub-id>
        </element-citation>
      </ref>
      <ref id="r185">
        <label>185</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ding</surname>
              <given-names>Z.M.</given-names>
            </name>
            <name>
              <surname>Babensee</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>S.I.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration.</article-title>
          <source>J. Immunol.</source>
          <year>1999</year>
          <volume>163</volume>
          <issue>9</issue>
          <fpage>5029</fpage>
          <lpage>5038</lpage>
          <pub-id pub-id-type="pmid">10528208</pub-id>
        </element-citation>
      </ref>
      <ref id="r186">
        <label>186</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pulkkinen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Uitto</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Mutation analysis and molecular genetics of epidermolysis bullosa.</article-title>
          <source>Matrix Biol.</source>
          <year>1999</year>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>29</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">10367729</pub-id>
        </element-citation>
      </ref>
      <ref id="r187">
        <label>187</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miner</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Cunningham</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sanes</surname>
              <given-names>J.R.</given-names>
            </name>
          </person-group>
          <article-title>Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain.</article-title>
          <source>J. Cell Biol.</source>
          <year>1998</year>
          <volume>143</volume>
          <issue>6</issue>
          <fpage>1713</fpage>
          <lpage>1723</lpage>
          <pub-id pub-id-type="pmid">9852162</pub-id>
        </element-citation>
      </ref>
      <ref id="r188">
        <label>188</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wagner</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Lohler</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tedder</surname>
              <given-names>T.F.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>L-selectin and beta7 integrin synergistically mediate lymphocyte migration to mesenteric lymph nodes.</article-title>
          <source>Eur. J. Immunol.</source>
          <year>1998</year>
          <volume>28</volume>
          <issue>11</issue>
          <fpage>3832</fpage>
          <lpage>3839</lpage>
          <pub-id pub-id-type="pmid">9842926</pub-id>
        </element-citation>
      </ref>
      <ref id="r189">
        <label>189</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ateeq</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Hsiung</surname>
              <given-names>S.H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.</article-title>
          <source>J. Med. Chem.</source>
          <year>1999</year>
          <volume>42</volume>
          <issue>5</issue>
          <fpage>920</fpage>
          <lpage>934</lpage>
          <pub-id pub-id-type="pmid">10072689</pub-id>
        </element-citation>
      </ref>
      <ref id="r190">
        <label>190</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abraham</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Gill</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A small-molecule, tight-binding inhibitor of the integrin alpha(4)beta(1) blocks antigen-induced airway responses and inflammation in experimental asthma in sheep.</article-title>
          <source>Am. J. Respir. Crit. Care Med.</source>
          <year>2000</year>
          <volume>162</volume>
          <issue>2 Pt 1</issue>
          <fpage>603</fpage>
          <lpage>611</lpage>
          <pub-id pub-id-type="pmid">10934094</pub-id>
        </element-citation>
      </ref>
      <ref id="r191">
        <label>191</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ravensberg</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Luijk</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Westers</surname>
              <given-names>P.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.</article-title>
          <source>Allergy</source>
          <year>2006</year>
          <volume>61</volume>
          <issue>9</issue>
          <fpage>1097</fpage>
          <lpage>1103</lpage>
          <pub-id pub-id-type="pmid">16918513</pub-id>
        </element-citation>
      </ref>
      <ref id="r192">
        <label>192</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diamant</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Kuperus</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Baan</surname>
              <given-names>R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.</article-title>
          <source>Clin. Exp. Allergy</source>
          <year>2005</year>
          <volume>35</volume>
          <issue>8</issue>
          <fpage>1080</fpage>
          <lpage>1087</lpage>
          <pub-id pub-id-type="pmid">16120091</pub-id>
        </element-citation>
      </ref>
      <ref id="r193">
        <label>193</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sircar</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Gudmundsson</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Synthesis and SAR of N-benzoyl-L-biphenylalanine derivatives: discovery of TR-14035, a dual alpha(4)beta(7)/alpha(4)beta(1) integrin antagonist.</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2002</year>
          <volume>10</volume>
          <issue>6</issue>
          <fpage>2051</fpage>
          <lpage>2066</lpage>
          <pub-id pub-id-type="pmid">11937364</pub-id>
        </element-citation>
      </ref>
      <ref id="r194">
        <label>194</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cortijo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sanz</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Iranzo</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats.</article-title>
          <source>Br. J. Pharmacol.</source>
          <year>2006</year>
          <volume>147</volume>
          <issue>6</issue>
          <fpage>661</fpage>
          <lpage>670</lpage>
          <pub-id pub-id-type="pmid">16432509</pub-id>
        </element-citation>
      </ref>
      <ref id="r195">
        <label>195</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beekman</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Colevas</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Cooney</surname>
              <given-names>K.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design.</article-title>
          <source>Clin. Genitourin. Cancer</source>
          <year>2006</year>
          <volume>4</volume>
          <issue>4</issue>
          <fpage>299</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="pmid">16729916</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" fig-type="figure" position="float">
      <label>Fig. (1)</label>
      <caption>
        <p>Integrin expressions in various respiratory diseases.</p>
      </caption>
      <graphic xlink:href="CMM-15-714_F1"/>
    </fig>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Distribution of integrins in the lungs and their association with respiratory diseases.</p>
      </caption>
      <table frame="border" rules="all" width="100%">
        <thead>
          <tr>
            <th valign="middle" colspan="3" align="center" scope="colgroup" rowspan="1">
<bold>Disease</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Integrin</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>ECM</bold>
</th>
            <th valign="middle" colspan="2" align="center" scope="colgroup" rowspan="1">
<bold>Cell Type</bold>
</th>
            <th valign="middle" colspan="2" align="center" scope="colgroup" rowspan="1">
<bold>Remarks</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Ref</bold>
</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="10" valign="middle" colspan="3" align="center" scope="row">Asthma</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">&#x3B1;1&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Collagen</td>
            <td rowspan="5" valign="middle" colspan="2" align="center">Endothelial cell</td>
            <td rowspan="5" valign="middle" colspan="2" align="center">* Activation of &#x3B1;1&#x3B2;1 and &#x3B1;2&#x3B2;1 on endothelial cells is essential for VEGF-induced angiogenesis <italic>in vivo</italic>.<break/>* Successful early vasculogenesis and angiogenesis require &#x3B1;5&#x3B2;1 integrin-fibronectin interactions <italic>in vivo</italic> and <italic>in vitro</italic>.<break/>* &#x3B1;v&#x3B2;3 and &#x3B1;v&#x3B2;5 are involved in angiogenesis of the lung microvascular bed.</td>
            <td rowspan="5" valign="middle" align="center" colspan="1">[<xref rid="r57" ref-type="bibr">57</xref>, <xref rid="r108" ref-type="bibr">108</xref>, <xref rid="r130" ref-type="bibr">130</xref>-<xref rid="r134" ref-type="bibr">134</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">&#x3B1;2&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Collagen</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">&#x3B1;5&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Fibronectin</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">&#x3B1;v&#x3B2;3</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Collagen;<break/>Fibronectin;<break/>Vitronectin</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">&#x3B1;v&#x3B2;5</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Collagen;<break/>Fibronectin;<break/>Vitronectin</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">&#x3B1;5&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Collagen;<break/>Fibronectin; Laminin</td>
            <td rowspan="3" valign="middle" colspan="2" align="center">Airway smooth muscle</td>
            <td rowspan="3" valign="middle" colspan="2" align="center">* Airway smooth muscle cells receive strong survival signals from fibronectin, laminin and collagen <italic>in vitro</italic>.<break/>* &#x3B1;5&#x3B2;1 and &#x3B1;7&#x3B2;1 are the transducer of survival signals from ECM.<break/>* Airway smooth muscle cells express &#x3B1;v&#x3B2;5<break/>* &#x3B1;v&#x3B2;5 contributes to asthmatic airway remodeling <italic>via</italic> TGF&#x3B2; activation</td>
            <td rowspan="3" valign="middle" align="center" colspan="1">[<xref rid="r47" ref-type="bibr">47</xref>, <xref rid="r56" ref-type="bibr">56</xref>, <xref rid="r62" ref-type="bibr">62</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">&#x3B1;7&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Laminin</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">&#x3B1;v&#x3B2;5</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Collagen;<break/>Fibronectin;<break/>Vitronectin</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">&#x3B1;4&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">VCAM-1;<break/>ICAM-4; Osteopontin</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Eosinophil;<break/>Lymphocyte;<break/>Monocyte;<break/>Macrophage;<break/>Basophil;<break/>Mast cell</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">* Eosinophils transmigrate across VCAM-1-expressing human pulmonary microvascular endothelial cells <italic>via</italic> &#x3B1;4&#x3B2;1 <italic>in vitro</italic>.<break/>* Osteopontin promotes leukocyte adhesion <italic>via</italic> &#x3B1;4&#x3B2;1 <italic>in vitro</italic>.<break/>* &#x3B1;4&#x3B2;1 expression correlates with the severity of asthma.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r61" ref-type="bibr">61</xref>, <xref rid="r116" ref-type="bibr">116</xref>-<xref rid="r118" ref-type="bibr">118</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">&#x3B1;E&#x3B2;7</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">E-cadherin</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">T lymphocyte</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">* Expression is enhanced on lymphocytes in bronchoalveolar lavage fluid of asthma patients.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r55" ref-type="bibr">55</xref>]</td>
          </tr>
          <tr>
            <td rowspan="2" valign="middle" colspan="3" align="center" scope="row">Emphysema</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">&#x3B1;9&#x3B2;1;<break/>&#x3B1;v&#x3B2;3;<break/>&#x3B1;v&#x3B2;5</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Fibulin-5</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Elastic fiber</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">* Fibulin-5 knockout mice exhibit disorganized elastic fiber system throughout the body.<break/>* Fibulin-5 knockout mice have tortuous aorta, severe emphysema and loose skin.<break/>* Fibulin-5 and its integrin partners stabilize and organize elastic fiber in the skin, lung and vasculature.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r135" ref-type="bibr">135</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">&#x3B1;v&#x3B2;6</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">TGF&#x3B2;</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Epithelial cell</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">* &#x3B2;6 knockout mice have marked induction of macrophage metalloelastase (MMP12) that degrades elastin.<break/>* &#x3B2;6-null mice develop age-dependent emphysema.<break/>* Loss of &#x3B1;v&#x3B2;6 mediated activation of latent TGF&#x3B2; leads to age-dependent pulmonary emphysema <italic>via</italic> alterations of Mmp12 expression.<break/>* Functional alteration in the TGF&#x3B2; activation pathway affects susceptibility to emphysema.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r64" ref-type="bibr">64</xref>, <xref rid="r65" ref-type="bibr">65</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="3" align="center" scope="row" rowspan="1">Epithelial injury and lung wound repair</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">&#x3B1;2&#x3B2;1;<break/>&#x3B1;3&#x3B2;1;<break/>&#x3B1;5&#x3B2;1;<break/>&#x3B1;6&#x3B2;1;<break/>&#x3B1;v;<break/>&#x3B2;5;<break/>&#x3B2;6</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Laminins;<break/>Collagen;<break/>Fibronectin;<break/>Vitronectin;<break/>Fibrinogen</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Epithelial cell</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">* Increased expression of &#x3B1;v, &#x3B2;5, &#x3B2;6 and &#x3B1;5 is observed at the edges of surface epithelial wounds in an <italic>in vivo</italic> xenograft model of human bronchial epithelium.<break/>* Similar up-regulation of &#x3B1;v, &#x3B2;5 and &#x3B2;6 is also seen in areas of undifferentiated airway from cystic fibrotic patients.<break/>* Integrins mediate wound repair on different constitutive ECM in a cultured human airway epithelial cell line.<break/>* &#x3B2;1 is required for epithelial cell migration and spreading for wound closure.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r32" ref-type="bibr">32</xref>, <xref rid="r136" ref-type="bibr">136</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="2" align="center" scope="row" rowspan="1">
              <bold>Disease</bold>
            </td>
            <td valign="middle" colspan="2" align="center" rowspan="1">
              <bold>Integrin</bold>
            </td>
            <td valign="middle" colspan="2" align="center" rowspan="1">
              <bold>ECM</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Cell Type</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Remarks</bold>
            </td>
            <td valign="middle" colspan="2" align="center" rowspan="1">
              <bold>Ref</bold>
            </td>
          </tr>
          <tr>
            <td rowspan="5" valign="middle" colspan="2" align="center" scope="row">NSCLC</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">&#x3B1;1</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Collagen</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Epithelial cell</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* KrasLA2/&#x3B1;1-null mice have decreased incidence of primary lung tumors and longer survival compared with KrasLA2/&#x3B1;1-wildtype mice.<break/>* Tumors are smaller, less vascularized, reduced cell proliferation and increased apoptosis.<break/>* &#x3B1;1&#x3B2;1 is required to drive the growth of Kras-induced NSCLC.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r58" ref-type="bibr">58</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="2" align="center" scope="row" rowspan="1">&#x3B1;5&#x3B2;1</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Fibronectin</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Epithelial cell</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* Lung cancer cell lines express high levels of &#x3B1;5.<break/>* Node negative NSCLC samples have &#x3B1;5 over-expression.<break/>* &#x3B1;5 expression is associated with the differentiation status of the cancer cells and the age of the patients.<break/>* The overall survival rate for patients with node-negative and over-expressed &#x3B1;5 NSCLS is lower than patients with tumour of normal &#x3B1;5 expression.<break/>* &#x3B1;5&#x3B2;1 over-expression and the lost expression of collagen matrices correlate with laminin metastasis of NSCLC.<break/>* Tumor cell survival and invasiveness are promoted by the enhanced expression of &#x3B1;5&#x3B2;1 in NSCLC.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r63" ref-type="bibr">63</xref>, <xref rid="r137" ref-type="bibr">137</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="2" align="center" scope="row" rowspan="1">&#x3B1;11</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Collagen;<break/>Fibroblast</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Stromal fibroblast</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* Interaction between the collagen matrix and stromal fibroblast <italic>via</italic> &#x3B1;11 regulates IGF2 expression.<break/>* IGF2 enhances NSCLC cell growth.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r52" ref-type="bibr">52</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="2" align="center" scope="row" rowspan="1">&#x3B1;v&#x3B2;3</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Osteopontin</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Epithelial cell</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* Promotes lung cancer progression and metastasis by boosting the &#x3B1;5&#x3B2;1-EGFR signaling.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r138" ref-type="bibr">138</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="2" align="center" scope="row" rowspan="1">&#x3B1;v&#x3B2;6</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Fibronectin</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Epithelial cell</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* Enhances the ability of tumor cells to adhere, migrate, and invade the fibronectin-rich matrix that surrounds NSCLC cells.<break/>* Activates the release of active TGF&#x3B2; from ECM to promote tumor progression and invasion.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r66" ref-type="bibr">66</xref>, <xref rid="r67" ref-type="bibr">67</xref>]</td>
          </tr>
          <tr>
            <td rowspan="2" valign="middle" colspan="2" align="center" scope="row">Pneumonia</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">&#x3B1;E&#x3B2;7</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">E-cadherin</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">T lymphocyte</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* Expression is enhanced on lymphocytes in bronchoalveolar lavage fluid in patients.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r55" ref-type="bibr">55</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="2" align="center" scope="row" rowspan="1">&#x3B2;2</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">VCAM;<break/>ICAM</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Leukocyte</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* Synergises with selectin on neutrophil adhesion to endothelial cell.<break/>* Aids in extravasation of leukocytes across the vascular endothelium.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r7" ref-type="bibr">7</xref>]</td>
          </tr>
          <tr>
            <td rowspan="3" valign="middle" colspan="2" align="center" scope="row">Pulmonary fibrosis</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">&#x3B1;4&#x3B2;1</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">VCAM;<break/>ICAM</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Fibroblast</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* Loss of &#x3B1;4&#x3B2;1 signaling <italic>via</italic> PTEN results in a migratory/invasive phenotype of fibrotic lung fibroblasts.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r51" ref-type="bibr">51</xref>]</td>
          </tr>
          <tr>
            <td rowspan="2" valign="middle" colspan="2" align="center" scope="row">&#x3B1;5&#x3B2;1</td>
            <td rowspan="2" valign="middle" colspan="2" align="center">Fibronectin</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Fibroblast</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* &#x3B1;5&#x3B2;1-fibronectin signaling is required and sufficient to induce lung fibroblast migration/invasion across basement membrane</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r51" ref-type="bibr">51</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">Pneumocyte;<break/>Endothelial cell;<break/>Mesenchymal cell;<break/>Fibroblast;<break/>Myofibroblast</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* &#x3B1;5&#x3B2;1 staining is apparent mainly on fibroblasts and differentiated myofibroblasts after 7 days of bleomycin treatment.<break/>* &#x3B1;5&#x3B2;1 plays a key role in the activation, proliferation, differentiation and increased ECM synthesis of these cells during pulmonary fibrogenesis.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r139" ref-type="bibr">139</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">
              <bold>Disease</bold>
            </td>
            <td valign="middle" colspan="3" align="center" rowspan="1">
              <bold>Integrin</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>ECM</bold>
            </td>
            <td valign="middle" colspan="2" align="center" rowspan="1">
              <bold>Cell Type</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Remarks</bold>
            </td>
            <td valign="middle" colspan="2" align="center" rowspan="1">
              <bold>Ref</bold>
            </td>
          </tr>
          <tr>
            <td rowspan="2" valign="middle" align="left" scope="row" colspan="1"/>
            <td valign="middle" colspan="3" align="center" rowspan="1">&#x3B1;v&#x3B2;6</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Collagen;<break/>Fibronectin</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Pneumocyte</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* &#x3B1;v&#x3B2;6 is over-expressed in penumocytes lining the alveolar ducts and alveoli of human lung fibrosis.<break/>* Partial inhibition of &#x3B1;v&#x3B2;6 activation <italic>via</italic> a blocking antibody inhibits murine TGF&#x3B2;-mediated pulmonary fibrosis without aggravating inflammation.<break/>* &#x3B1;v&#x3B2;6, an activator of TGF&#x3B2;, is involved in the pathophysiology of human pulmonary fibrosis.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r68" ref-type="bibr">68</xref>, <xref rid="r69" ref-type="bibr">69</xref>, <xref rid="r89" ref-type="bibr">89</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="3" align="center" scope="row" rowspan="1">&#x3B1;E&#x3B2;7</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">E-cadherin</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">T lymphocyte</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* Expression is enhanced on lymphocytes in bronchoalveolar lavage fluid in patients.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r55" ref-type="bibr">55</xref>]</td>
          </tr>
          <tr>
            <td rowspan="5" valign="middle" align="center" scope="row" colspan="1">Sarcoidosis</td>
            <td valign="middle" colspan="3" align="center" rowspan="1">&#x3B1;4&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">VCAM;<break/>ICAM</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Alveolar T lymphocyte;<break/>Granuloma lymphocyte</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* &#x3B1;4&#x3B2;1 is over-expressed in human lymphocytes during the active phase of the disease.<break/>* Interaction between VCAM-1 and &#x3B1;4&#x3B2;1 is important for the extravasation of lymphocytes to the inflammatory site within the lung.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r49" ref-type="bibr">49</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="3" align="center" scope="row" rowspan="1">&#x3B1;5&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Fibronectin</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Alveolar T lymphocyte;<break/>Granuloma lymphocyte;<break/>Epitheloid cell;<break/>Fibroblast</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* &#x3B1;5&#x3B2;1 is over-expressed in human lymphocytes, epitheloid cells and fibroblasts during the active phase of the disease.<break/>* Interaction is important for cell proliferation, cytokine production, and cell differentiation.<break/>* &#x3B1;5&#x3B2;1-fibronectin binding is important for adhesion of leukocytes to the endothelial cells, to migrate into inflammatory sites and to remain at the affected sites <italic>via</italic> ECM binding.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r49" ref-type="bibr">49</xref>, <xref rid="r50" ref-type="bibr">50</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="3" align="center" scope="row" rowspan="1">&#x3B1;1&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Collagen</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Alveolar T lymphocyte</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* &#x3B1;1&#x3B2;1 is over-expressed in human lymphocytes during the active phase of the disease.<break/>* The chronically stimulated lung T cells are compartmentalized on the alveolar epithelial surface and are gradually exchanged with the systemic immune system <italic>via</italic> &#x3B1;1&#x3B2;1 integrin.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r49" ref-type="bibr">49</xref>, <xref rid="r140" ref-type="bibr">140</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="3" align="center" scope="row" rowspan="1">&#x3B1;6&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Laminin</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Granuloma lymphocyte</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* &#x3B1;6&#x3B2;1 is over-expressed in human lymphocytes during the active phase of the disease.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r49" ref-type="bibr">49</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="3" align="center" scope="row" rowspan="1">&#x3B1;2&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Collagens</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">Fibroblast</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">* &#x3B1;2&#x3B2;1 is over-expressed in human lymphocytes during the active phase of the disease.</td>
            <td valign="middle" colspan="2" align="center" rowspan="1">[<xref rid="r49" ref-type="bibr">49</xref>, <xref rid="r50" ref-type="bibr">50</xref>]</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="T2" position="float">
      <label>Table 2</label>
      <caption>
        <p>Effect of integrin knockout in the lung development of mice.</p>
      </caption>
      <table frame="border" rules="all" width="100%">
        <thead>
          <tr>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Integrin Knockout</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Phenotype of Mice</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Impact on Lung Development</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Ref</bold>
</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;1</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Viable and fertile.<break/>* No overt phenotype.<break/><underline>Vasculature</underline><break/>* Increased collagen synthesis.<break/>* Increased Mmp7 and Mmp9 synthesis.<break/>* Increased plasma levels of angiostatin.<break/>* Implanted tumors show reduced vascularization.<break/><underline>Skin</underline><break/>* Embryonic fibroblasts fail to spread and migrate on collagen IV and laminin <italic>in vitro</italic>.<break/>* Hypocellular dermis.<break/>* Reduced embryonic dermal fibroblast proliferation.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Isolated &#x3B1;1-null endothelial cells from the lung show reduced proliferation on substrata.<break/>* Role of &#x3B1;1 integrin in agiogenesis is not restricted to tumor endothelial cells only.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r108" ref-type="bibr">108</xref>, <xref rid="r141" ref-type="bibr">141</xref>-<xref rid="r143" ref-type="bibr">143</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;2</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Viable, normal development and fertile.<break/>* No obvious anatomical or histological differences.<break/><underline>Vasculature</underline><break/>* Display partially defective platelet adhesion to collagen.<break/>* Platelets aggregate very slowly in the presence of collagen.<break/>* No bleeding anomalies.<break/><underline>Mammary Gland</underline><break/>* Defects in branching morphogenesis of mammary gland.<break/><underline>Immunity</underline><break/>* Normal number of mast cells.<break/>* Do not support mast cell-mediated inflammatory responses.<break/>* Defects in innate immune response to <italic>Listeria monocytogenes</italic>.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* No abnormalities.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r144" ref-type="bibr">144</xref>-<xref rid="r147" ref-type="bibr">147</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;3</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Survive to birth but die during the neonatal period.<break/><underline>Kidney</underline><break/>* Defective branching of the medullary collecting duct despite normal number of nephrons.<break/>* Proximal tubule epithelial cells contain excess lysosomes and exhibit microcystic.<break/>* Disorganized glomerular basement membrane.<break/><underline>Skin</underline><break/>* Disorganized basement membrane of the skin.<break/>* Skin blistering at the dermal-epidermal junction.<break/><underline>Brain</underline><break/>* Abnormal layering of the cerebral cortex.<break/>* Developing cerebral cortex shows adhesive preference switch from glial cells to neuronal tissues.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Decreased bronchus branching.<break/>* Large bronchi extend into the periphery.<break/>* Reduced maturation of distal bronchiolar.<break/>* &#x3B1;3 is important in regulating basement membrane organization and branching morphogenesis.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r109" ref-type="bibr">109</xref>-<xref rid="r111" ref-type="bibr">111</xref>, <xref rid="r148" ref-type="bibr">148</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;4</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Embryonically lethal.<break/><underline>Placenta</underline><break/>* Defects in chorroallantois fusion during placental development.<break/><underline>Heart</underline><break/>* Abnormal development of the cardiac epicardium.<break/>* Lack coronary vessels.<break/>* Cardiac hemorrhage.<break/><underline>Face</underline><break/>* Abnormalities in the cranial and facial structure.<break/><underline>Lymphatic system</underline><break/>* Defects in lymphoid and myeloid lineage development.<break/>* Defects in lymphocyte homing to Peyer&#x2019;s patches.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r149" ref-type="bibr">149</xref>-<xref rid="r151" ref-type="bibr">151</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">
              <bold>Integrin Knockout</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Phenotype of Mice</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Impact on Lung Development</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Ref</bold>
            </td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;5</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Embryonically lethal.<break/><underline>Embroyonic Development</underline><break/>* Defects in extraembryonic and embryonic vasculature.<break/>* Defects in posterior trunk and yolk sac mesodermal structures.<break/><underline>Vasculature</underline><break/>* Severe vascular defect.<break/><underline>Skeletal Muscle</underline><break/>* Develop typical alterations resembling muscular dystrophy.<break/>* Reduced adhesion and survival of myoblasts.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Signs of thorax muscle degeneration.<break/>* &#x3B1;5 maintains muscle integrity.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r152" ref-type="bibr">152</xref>-<xref rid="r155" ref-type="bibr">155</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;6</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Die shortly after birth.<break/><underline>Brain</underline><break/>* Abnormal laminar organization of the cerebral cortex.<break/>* Ectopic neuroblastic outgrowth on the brain surface.<break/>* Altered laminin deposition in the mutant brains.<break/><underline>Eye</underline><break/>* Abnormal laminar organization of the eye.<break/>* Ectopic neuroblastic outgrowth on the eye.<break/><underline>Skin</underline><break/>* Severe skin blistering.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* No abnormalities.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r112" ref-type="bibr">112</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;7</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Viable and fertile.<break/><underline>Skeletal Muscle</underline><break/>* Develop symptoms of progressive muscular dystrophy soon after birth.<break/>* Severe disruption of the myotendinous junctions.<break/><underline>Heart</underline><break/>* Congenital myopathies.<break/><underline>Central Nervous System</underline><break/>* Delayed motor milestones.<break/>* Impaired axonal regeneration.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r156" ref-type="bibr">156</xref>, <xref rid="r157" ref-type="bibr">157</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;8</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Die soon after birth.<break/><underline>Kidney</underline><break/>* Profound deficits in kidney morphogenesis.<break/>* Reduced branching and growth of the uretic bud.<break/>* Mesenchymal cells fail to be recruited into the kidney epithelial structures.<break/><underline>Ear</underline><break/>* Lacked / malformed stereocilia on hair cells in the utricle.<break/>* Difficulty in balancing due to structural defects of the inner ear.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r158" ref-type="bibr">158</xref>, <xref rid="r159" ref-type="bibr">159</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;9</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Born alive but develop bilateral chylothorax.<break/>* Despite temporal and spatial expression of &#x3B1;9 on nonlymphatic tissues (epithelium, airway and gut smooth muscle, choroid plexus and liver) during development, its expression was not altered.<break/><underline>Bone</underline><break/>* Severe neutropenia due to the loss of &#x3B1;9 in bone marrow cells.<break/><underline>Lymphatic system</underline><break/>* Develop edema and lymphocytic infiltration in the chest wall.<break/>* Abnormality in lymphatic development.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Respiratory failure caused by an accumulation of large volumes of pleural fluid.<break/>* &#x3B1;9 plays a critical role in development of the thoracic duct and other lymphatic vessels.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r114" ref-type="bibr">114</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">
              <bold>Integrin Knockout</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Phenotype of Mice</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Impact on Lung Development</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Ref</bold>
            </td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;10</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not reported</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"/>
            <td valign="middle" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;v</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Embryonically lethal.<break/>* Conditional knockout of &#x3B1;v on myofibroblasts in multiple organs<break/><underline>Organs</underline><break/>* Conditional knockout of &#x3B1;v on myofibroblasts in liver, lung and kidney inhibited fibrosis in these organs<break/><underline>Vasculature</underline><break/>* Defects in placenta, central nervous system, and gastrointestinal blood vessels.<break/>* Exhibit intracerebral and intestinal hemorrhages.<break/>* Extensive vasculogenesis and angiogenesis in knockout mice despite the role of &#x3B1;v integrin in vascular development.<break/><underline>Mouth</underline><break/>* Cleft palates.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r160" ref-type="bibr">160</xref>, <xref rid="r161" ref-type="bibr">161</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;L</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"><underline>Immunity</underline><break/>* Impaired lymphocyte recirculation and homotypic interactions.<break/>* Reduced leukocyte proliferation in response to mixed lymphocyte reaction and growth factor <italic>in vitro</italic> despite normal cytotoxic T cell responses.<break/>* No rejection of immunogenic tumors grafted into footpads.<break/>* No priming responses towards tumor-specific antigen.<break/>* Impaired induction of peripheral immune responses but respond to systemic infection.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r162" ref-type="bibr">162</xref>-<xref rid="r164" ref-type="bibr">164</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;M</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Obesity.<break/><underline>Immunity</underline><break/>* Impaired phagocytosis, polymorphonuclear leucocytes (PMN) apoptosis, and mast cell development.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r165" ref-type="bibr">165</xref>-<xref rid="r167" ref-type="bibr">167</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;E</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"><underline>Immunity</underline><break/>* Reduced number of intestinal and vaginal intraepithelial lymphocytes.<break/>* Diminished lamina propia T lymphocytes numbers.<break/>* Number of T lymphocytes is not altered in Peyer&#x2019;s patch and spleen.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Peribronchial and intrapulmonary T lymphocytes numbers are not reduced.<break/>* &#x3B1;E plays a role in generating and maintaining the gut and vaginal T lymphocytes (but not in the lungs).</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r168" ref-type="bibr">168</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;IIb</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"><underline>Vasculature</underline><break/>* Defective platelet function caused by the failure of platelets to bind fibrinogen, to aggregate and to retract fibrin clot.<break/>* Lack of fibrinogen in platelet granules.<break/>* Increased rebleeding tendency similar to Glanzmann thrombasthenia in humans.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r169" ref-type="bibr">169</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;X</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not reported.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"/>
            <td valign="middle" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;D</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not reported.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"/>
            <td valign="middle" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B2;1</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Peri-implantation lethality.<break/><underline>Embroyonic Development</underline><break/>* Inner cell mass deterioration due to the lost of &#x3B2;1 integrin-mediated survival signaling.<break/><underline>Heart</underline><break/>* Cardiac muscle in the heart becomes smaller and degenerates.<break/>* Alterations in the sarcomeric architecture.<break/>* Hypertrophic changes in the heart.<break/>* Display replacement fibrosis - the formation of fibrous tissues at sites where the cells are atrophied, degenerated and necrotic.<break/><underline>Bone</underline><break/>* Impaired membranous bone formation, characterized by decreased cortical bone formation and reduced bone mass in cortical and flat bones.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r170" ref-type="bibr">170</xref>-<xref rid="r174" ref-type="bibr">174</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">
              <bold>Integrin Knockout</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Phenotype of Mice</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Impact on Lung Development</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Ref</bold>
            </td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B2;2</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"><underline>Immunity</underline><break/>* Impaired leukocyte recruitment.<break/>* Develop chronic dermatitis with extensive erosion on face and submandibular region.<break/>* Increased neutrophil counts, elevated immunoglobulin levels, splenomegaly, lymphadenopathy and abundant plasma cells in skin, gut, kidney and lymph nodes.<break/>* Severe defect in T cell proliferation.<break/>* Reduced neutrophil extravasation into infected tissues during irritant dermatitis.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* In pneumonia, the neutrophil emigration in lung section is not reduced compared to wild type mice.<break/>* &#x3B2;2 is essential only for dermal neutrophil emigration during skin infection.<break/>* Reduced number of dendritic cells in the lung, alveolar wall, large and small airways.<break/>* &#x3B2;2 is required for dendritic cell migration into the lung.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r175" ref-type="bibr">175</xref>-<xref rid="r177" ref-type="bibr">177</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B2;3</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Viable and fertile.<break/><underline>Vasculature</underline><break/>* Display cardinal features of Glanzmann thrombasthenia - defective platelet aggregation, impaired clot retraction and increased rebleeding tendency.<break/>* Reduced survival and anemia due to postnatal hemorrhage.<break/><underline>Placenta</underline><break/>* Placental defects leading to fetal mortality despite normal implantation.<break/><underline>Bone</underline><break/>* Develop osteosclerosis - increased bone mass with age.<break/>* Contain more osteoclasts despite increased bone mass. However, osteoclasts are dysfunctional as evidenced by significant hypocalcemia in knockout mice.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r178" ref-type="bibr">178</xref>-<xref rid="r180" ref-type="bibr">180</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B2;4</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Die shortly after birth.<break/>* &#x3B1;6 subunit significantly downregulated.<break/><underline>Skin</underline><break/>* Display pathological phenotype similar to human junctional epidermolysis bullosa.<break/>* Skin blistering with severe epidermis and squamous epithelial detachment.<break/>* Reduced skin adhesive properties due to the absence of hemidesmosomes.<break/>* Epithelial tissues show signs of degeneration and disorganization.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r44" ref-type="bibr">44</xref>, <xref rid="r181" ref-type="bibr">181</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B2;5</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Develop, grow and reproduce normally.<break/><underline>Skin</underline><break/>* Harvested keratinocytes demonstrate defects in migration and adhesion on vitronectin <italic>in vitro</italic>. However, cutaneous wound healing is the same as wild type mice.<break/><underline>Eye</underline><break/>* Age-related blindness.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Protection from increased vascular permeability in a model of acute lung injury.<break/>* &#x3B2;5 from pulmonary endothelial cells regulates vascular permeability in acute lung injury.<break/>* &#x3B2;5 deletion did not affect adenovirus infection.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r182" ref-type="bibr">182</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B2;6</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"><underline>Skin</underline><break/>* Skin inflammation.<break/>* Juvenile baldness due to macrophage infiltration to the dermis of the affected area.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Accumulation of activated lymphocytes around conducting airways during lung inflammation. Hence, there is airway hyperresponsiveness to increasing acetylcholine stimulation.<break/>* &#x3B2;6 regulates local inflammation of lung epithelial cells.<break/>* &#x3B2;6 activates TGF&#x3B2;, a signaling pathway essential for pulmonary fibrosis. Hence, these mice are protected from lung fibrosis.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r64" ref-type="bibr">64</xref>, <xref rid="r89" ref-type="bibr">89</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B2;7</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"><underline>Gut associated Lymphoid Tissue (GALT)</underline><break/>* Abnormal Peyer&#x2019;s patches.<break/>* Defective migration of T cells to Payer&#x2019;s patches.<break/>* Decreased number of lamina propia intraepithelial lymphocytes.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* &#x3B2;7 is required for lymphocytes to adhere on vasculature at the site for transmigration into the GALT.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r183" ref-type="bibr">183</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">
              <bold>Integrin Knockout</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Phenotype of Mice</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Impact on Lung Development</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Ref</bold>
            </td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B2;8</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"><underline>Vasculature</underline><break/>* Defects in placenta, central nervous system and gastrointestinal blood vessels.<break/><underline>Mouth</underline><break/>* Cleft palate.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r184" ref-type="bibr">184</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;v&#x3B2;6</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Marked increase in macrophage metalloelastase level (MMP12)</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Loss of &#x3B1;v&#x3B2;6-mediated activation of latent TGF&#x3B2; causes age-dependent pulmonary emphysema through alterations in macrophage MMP12 expression.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r65" ref-type="bibr">65</xref>, <xref rid="r89" ref-type="bibr">89</xref>, <xref rid="r185" ref-type="bibr">185</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;6&#x3B2;4</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"><underline>Skin</underline><break/>* Complete absence of hemidesmosomes.<break/>* Skin blistering leading to postnatal death.<break/>* Epidermolysis bullosa with congenital pyloric atresia.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r186" ref-type="bibr">186</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;5 and &#x3B1;v</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Embryonically lethal.<break/><underline>Embroyonic Development</underline><break/>* Display severe gastrulation defect with a lack of anterior mesoderm.<break/>* Severe amniotic defect similar to fibronectin-null mice.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r153" ref-type="bibr">153</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;3 and &#x3B1;6</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Growth retarded.<break/><underline>Limb</underline><break/>* Limb abnormalities - syndactyly and fusion of preskeletal elements.<break/>* Defects in the apical ectodermal ridge, a limb organizing centre.<break/><underline>Brain</underline><break/>* Exencephaly - absence of neural tube closure.<break/>* Cortical disorganization<break/><underline>Kidney</underline><break/>* Kidney defects<break/>* Structural disorganization and reduced proliferation of the ridge cells.<break/><underline>Eye</underline><break/>* Eye lamination defects</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Develop bilateral lung hypoplasia<break/>* &#x3B1;3 and &#x3B1;6 integrins are required for structural organization of presumptive ectodermal ridge cells for normal lung development.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r113" ref-type="bibr">113</xref>, <xref rid="r155" ref-type="bibr">155</xref>, <xref rid="r187" ref-type="bibr">187</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B2;7 and L-selectin</td>
            <td valign="middle" align="left" rowspan="1" colspan="1"><underline>Immunity</underline><break/>* Suffer from a nearly complete impairment of lymphocyte migration to mesenteric lymph nodes (MLN).<break/>* Impaired MLN formation.<break/>* T lymphocyte numbers drastically reduced compared to control mice.</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Not determined.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r188" ref-type="bibr">188</xref>]</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="T3" position="float">
      <label>Table 3</label>
      <caption>
        <p>Targeted integrins in clinical trials.</p>
      </caption>
      <table frame="border" rules="all" width="100%">
        <thead>
          <tr>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Targeted Integrin</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Drug Name</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Clinical Stage</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Remarks</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Respiratory Disease Target</bold>
</th>
            <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Ref</bold>
</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="6" valign="middle" align="center" scope="row" colspan="1">&#x3B1;4&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Valategrast (R411)</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Terminated at Phase II</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Attenuates cellular trafficking of activated CD4+ T cells and eosinophils in lung airways mediated by &#x3B1;4-VCAM-1 interactions.<break/>* Terminated after clarification of the regulatory framework for this class of compounds.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Asthma</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r9" ref-type="bibr">9</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">IVL745</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Terminated at Phase II</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Reduces the percentage of eosinophils in sputum.<break/>* Inhibits antigen-induced eosinophil and lymphocyte accumulation.<break/>* Prevents eosinophil extravasations.<break/>* Terminated because there is no statistical significant of IVL745 treatment on the early and late asthmatic responses, methacholine hyperresponsiveness, symptoms and exhaled nitric oxide compared with placebo.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Asthma</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r120" ref-type="bibr">120</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">Bio-1211</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Terminated at Phase II</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Reduces the recruitment of VLA-4 expressing cells- eosinophils, lymphocytes, metachromatic staining cells and neutrophils to the airways.<break/>* Interferes with inflammatory cell degranulation.<break/>* Terminated due to the lack of drug efficacy in asthmatic patients.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Asthma</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r189" ref-type="bibr">189</xref>, <xref rid="r190" ref-type="bibr">190</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">GW-559090X</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Terminated at Phase II</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Inhibits eosinophil recruitment and allergen induced airway hyperresponsiveness in rat and guinea pig models of ovalbumin-induced lung inflammation.<break/>* Terminated because it does not reduce the early and late asthmatic response in a population of atopic asthmatic patients.<break/>* Not effective in allergen-induced airway hyperresponsiveness or exhaled nitric oxide levels of asthmatic patients.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Asthma</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r191" ref-type="bibr">191</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">HMR 1031</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Terminated at Phase II</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Substantially reduces allergen-induced airway inflammatory and airway hyperresponsiveness in sensitized mice and sheep respectively.<break/>* Terminated due to lack of effect in subjects with atopic asthma.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Asthma</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r192" ref-type="bibr">192</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" colspan="1" align="center" scope="row" rowspan="1">TR14035</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Phase I</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Dual antagonist for &#x3B1;4&#x3B2;1/&#x3B1;4&#x3B2;7-mediated leukocyte cell adhesion.<break/>* Suppresses airway hyperrespoinsiveness to 5-HT and reduces the number of eosinophils, neutrophils, lymphocytes and macrophages in bonchoalveolar lavage fluid of sensitized Brown Norway rats.<break/>* Blocks VCAM/VLA-4 interactions and allergen-induced airway responses in a sheep model of asthma.<break/>* This drug was reported to be in Phase I clinical trial for asthma. Since this drug is no longer listed under GSK&#x2019;s pipeline, the status of the current development of this drug is unknown.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Asthma</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r193" ref-type="bibr">193</xref>, <xref rid="r194" ref-type="bibr">194</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;4&#x3B2;1;<break/>&#x3B1;4&#x3B2;7</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Vitaxin II applied in combination with cancer therapy</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Phase I</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Ongoing study with no data reported yet.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">NSCLC</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r19" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;5&#x3B2;1</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Volociximab</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Phase II</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Exhibit encouraging safety profiles in Phase I clinical trial.<break/>* Ongoing study with no data reported yet.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">NSCLC</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r129" ref-type="bibr">129</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">
              <bold>Targeted Integrin</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Drug Name</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Clinical Stage</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Remarks</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Respiratory Disease Target</bold>
            </td>
            <td valign="middle" align="center" rowspan="1" colspan="1">
              <bold>Ref</bold>
            </td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;v&#x3B2;3</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">ACDCRGDCFC<break/>peptide<break/>conjugated<break/>with<break/>antimicrobial<break/>synthetic<break/>peptide<break/>(KLAKLAK)<sub>2</sub></td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Preclinical</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* ACDCRGDCFC - a targeting domain to guide the &#x201C;homing&#x2019; proapoptotic peptide to the targeted cells and allow internalization.<break/>* (KLAKLAK)<sub>2</sub> - a proapoptotic domain designed to be non-toxic outside the cells but toxic when internalized into targeted cells by the disruption of mitochondrial membranes.<break/>* Significant tumor-reducing effect.<break/>* Able to lower the lung metastasis burden.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">NSCLC</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r127" ref-type="bibr">127</xref>]</td>
          </tr>
          <tr>
            <td valign="middle" align="center" scope="row" rowspan="1" colspan="1">&#x3B1;v&#x3B2;3;<break/>&#x3B1;v&#x3B2;5</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Cilengitide</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">Phase II</td>
            <td valign="middle" align="left" rowspan="1" colspan="1">* Exhibit encouraging safety profiles in Phase I clinical trial.<break/>* Ongoing study with no data reported yet.</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">NSCLC</td>
            <td valign="middle" align="center" rowspan="1" colspan="1">[<xref rid="r128" ref-type="bibr">128</xref>, <xref rid="r195" ref-type="bibr">195</xref>]</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>